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Abstract 
Neurogenic orthostatic hypotension (NOH) is characterized by a drop in systolic blood pressure 
≥20mmHg or diastolic blood pressure ≥10mmHg within three minutes of upright posture. A large 
drop in blood pressure can trigger cerebral hypoperfusion, which has been linked to deficits in 
cognitive function. The current thesis aimed to measure cerebral hemodynamics and cognitive 
function in 20 NOH patients and 20 controls in the supine and head-up tilt (HUT) positions. 
Information processing speed (IPS) was assessed using the Symbol-Digit Modalities Test and 
attention was measured using the Stroop Test. NOH patients had significantly slower IPS in both 
the supine(p<0.001) and HUT(p<0.001) positions and had worse attention during HUT(p=0.029) 
compared to controls. During HUT, NOH patients had significantly reduced cerebral blood flow 
velocity(p=0.003) and cerebral oxygen saturation(p=0.025) from baseline, whereas controls 
revealed no significant changes. Decreased cerebral hemodynamics in NOH patients could be 
linked to their impairment in IPS and attention.  
 
Keywords: neurogenic orthostatic hypotension, cognitive function, information processing 
speed, attention, regional cerebral oxygen saturation, cerebral blood flow velocity 
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Summary for Lay Audience 
Neurogenic orthostatic hypotension (NOH) is characterized by a drop in in systolic blood pressure 
≥ 20mmHg or diastolic blood pressure ≥ 10mmHg within three minutes of upright posture. A 
severe drop in blood pressure can cause symptoms such as lightheadedness, dizziness, weakness, 
and fatigue. This thesis objected to determine if patients with NOH experienced alterations in 
cognitive function with a positional change from lying to standing. Cognitive function was 
assessed using the Symbol-Digit Modalities Test to measure information processing speed and the 
Stroop Test to measure attention. Recent research proposed that reductions in cerebral blood 
supply can accelerate the natural process of cognitive decline. Therefore, this thesis also aimed to 
measure cerebral blood flow using transcranial doppler and near infrared spectroscopy to 
determine if there were any differences between NOH patients and healthy control subjects. It was 
found that NOH patients had significantly slower information processing speed in both the lying 
and standing positions compared to controls, as well NOH patients had significantly reduced 
attention in the standing position compared to controls. Patients with NOH experienced a 
significant reduction in cerebral blood flow in the standing position compared to the lying position. 
Repeated exposure to reduced cerebral blood flow as a result of autonomic dysfunction is likely a 
contributing factor to our finding of impaired information processing speed and attention in NOH 
patients. This thesis sheds new light on cognitive function and cerebral blood flow in NOH 
patients. 
 
 
 
 
 iv 
 
Acknowledgments 
I would first like to thank my amazing supervisor Dr. Kurt Kimpinski. From day one you have 
supported me in every way possible. You ensured I had a smooth transition into my master’s 
degree by organizing research ideas with me before my degree commenced. You provided me with 
a clinical experience that allowed me access to patients for my research. You enhanced my 
education by providing me with the opportunity to present my research findings at a conference. 
Thank you for holding weekly meetings to ensure I was on track with my project and being 
available to speak with me at any time. I am beyond grateful for your guidance and support 
throughout this whole process.  
 
Thank you to my committee members Dr. Sarah Morrow and Dr. Tim Doherty for providing me 
with additional information and resources related to my research. Thank you for taking the time to 
meet with me and providing me with advice. As well, thank you to my thesis examiners, Dr. Anita 
Christie, Dr. John Kowalchuk, and Dr. Sarah Morrow for your evaluation of my thesis. 
 
I owe much gratitude to my lab mates; Faizan, Rasha, and Jacquie for all your assistance with my 
research project. Thank you, Jacquie for all your helpful tips and pointers on how to navigate a 
master’s degree. Thank you, to the best secretary Kim Masseo for your support and for organizing 
all meetings necessary for my degree. 
 
Thank you to my parents Karen and Alan and my siblings Jocelyn and Grant for your continuous 
love and support throughout my degree. Thank you, Mom for helping me find participants for my 
study and for being my biggest cheerleader. Thank you, Jocelyn for being there for me and 
spending time with me when I needed a break to socialize. Thank you, Grant for telling me I’m 
the smartest person you know and that I can do anything. Thank you, Dad for inspiring me to 
 v 
 
complete a master’s degree, I’ve looked up to you my whole life. Thank you, Grandma Sheila for 
all the love you have provided me and for participating in my research. 
 
Thank you to my best friends Alainna and Kelly for being there for me every day and for listening 
to me continually talk about my research. Thank you, Alainna for volunteering to be my very first 
guinea pig to practice my research protocol on. 
 
Lastly, I would also like to thank all the participants who volunteered their time to complete my 
research study.  
 
 
 
 
 
 
 
 
 
 
 
 vi 
 
Table of Contents 
Abstract ............................................................................................................................... ii 
Summary for Lay Audience ............................................................................................... iii 
Acknowledgments.............................................................................................................. iv 
Table of Contents ............................................................................................................... vi 
List of Tables ...................................................................................................................... x 
List of Figures .................................................................................................................... xi 
List of Appendices ............................................................................................................ xii 
List of Abbreviations ....................................................................................................... xiii 
Chapter 1 ........................................................................................................................... 1 
1 Introduction .................................................................................................................... 1 
Chapter 2 ........................................................................................................................... 3 
2 Literature Review ........................................................................................................... 3 
2.1 Autonomic Nervous System ................................................................................... 3 
2.2 Autonomic Dysfunction .......................................................................................... 6 
2.3 Neurogenic Orthostatic Hypotension (NOH) ......................................................... 7 
2.4 Diagnostic Tests for NOH ...................................................................................... 8 
2.4.1 Quantitative Sudomotor Axon Reflex Test (QSART) ................................ 8 
2.4.2 Heart Rate Variability to Deep Breathing ................................................. 10 
2.4.3 Valsalva Maneuver ................................................................................... 12 
2.4.4 Head-Up Tilt ............................................................................................. 14 
2.5 Treatment of NOH ................................................................................................ 16 
2.5.1 Non-pharmacological Treatment .............................................................. 16 
2.5.2 Pharmacological Treatment ...................................................................... 16 
 vii 
 
2.6 Cerebral Hemodynamics ....................................................................................... 17 
2.7 Transcranial Doppler ............................................................................................ 17 
2.8 Near Infrared Spectroscopy .................................................................................. 18 
2.9 Cerebral Hemodynamics &Autonomic Dysfunction ............................................ 19 
2.10   Normal Aging and Cognitive Decline ................................................................ 21 
2.11   Cognitive Decline Associated with Disease ....................................................... 22 
2.12   Cognitive Function and its Relationship to NOH .............................................. 23 
2.13   Cognitive Tests ................................................................................................... 25 
2.13.1 Symbol Digit Modalities Test ................................................................... 25 
2.13.2 Stroop Test ................................................................................................ 26 
2.14   Conclusion .......................................................................................................... 27 
2.15   References .......................................................................................................... 28 
Chapter 3 ......................................................................................................................... 37 
3 Neurogenic orthostatic hypotension impairs information processing speed                        
and attention  ................................................................................................................ 37 
3.1 Introduction ........................................................................................................... 37 
3.2 Methods................................................................................................................. 39 
3.2.1 Participants ................................................................................................ 39 
3.2.2 Physiological Measures ............................................................................ 39 
3.2.3 Cognitive Measures .................................................................................. 40 
3.2.4 Statistical Analysis .................................................................................... 41 
3.3 Results ................................................................................................................... 41 
3.3.1 Participants ................................................................................................ 41 
3.3.2 Hemodynamic Measurements ................................................................... 42 
3.3.3 Symbol Digit Modalities Test Scores ....................................................... 44 
3.3.4 Stroop Test Scores .................................................................................... 44 
 viii 
 
3.3.5 Correlation between Blood Pressure & Cognitive Testing ....................... 44 
3.3.6 MMSE and MoCA Scores ........................................................................ 49 
3.4 Discussion ............................................................................................................. 49 
3.5 Conclusion ............................................................................................................ 53 
3.6 References ............................................................................................................. 54 
Chapter 4 ......................................................................................................................... 58 
4 The influence of cerebral hemodynamics on information processing speed and        
attention in patients with neurogenic orthostatic hypotension ..................................... 58 
4.1 Introduction ........................................................................................................... 58 
4.2 Methods................................................................................................................. 60 
4.2.1 Participants ................................................................................................ 60 
4.2.2 Physiological Measures ............................................................................ 61 
4.2.3 Cognitive Measures .................................................................................. 61 
4.2.4 Statistical Analysis .................................................................................... 62 
4.3 Results ................................................................................................................... 63 
4.3.1 Participants ................................................................................................ 63 
4.3.2 SDMT and Stroop Test Scores ................................................................. 64 
4.3.3 Cerebral Blood Flow Velocity .................................................................. 65 
4.3.4 Regional Cerebral Oxygen Saturation ...................................................... 68 
4.3.5 Mean Arterial Pressure ............................................................................. 71 
4.4 Discussion ............................................................................................................. 74 
4.5 Conclusion ............................................................................................................ 77 
4.6 References ............................................................................................................. 78 
Chapter 5 ......................................................................................................................... 82 
5 General Discussion....................................................................................................... 82 
5.1 Supported and Rejected Hypotheses ..................................................................... 82 
 ix 
 
5.2 Strengths and Limitations ..................................................................................... 83 
5.3 Future Directions .................................................................................................. 84 
5.4 Conclusion ............................................................................................................ 85 
Appendices ........................................................................................................................ 86 
Curriculum Vitae .............................................................................................................. 91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 x 
 
List of Tables 
 
Table 1. Participant Characteristics .............................................................................................. 42 
Table 2.  Physiological Characteristics ......................................................................................... 43 
Table 3. Participant Characteristics .............................................................................................. 63 
Table 4. Cognitive test scores in Supine and HUT Positions ....................................................... 64 
 
 xi 
 
List of Figures 
 
Figure 1. The Autonomic Nervous System 13 ................................................................................. 5 
Figure 2. QSART in A) Healthy Individual and B) NOH Patient .................................................. 9 
Figure 3. Deep Breathing Task in A) Healthy Individual and B) NOH Patient ........................... 11 
Figure 4. Valsalva Maneuver in A) Healthy Individual and B) NOH Patient .............................. 13 
Figure 5. Head-up Tilt in A) Healthy Individual and B) NOH Patient......................................... 15 
Figure 6. Mean SDMT Scores in the Supine and HUT Positions ................................................ 45 
Figure 7. Stroop Test Scores in the Supine and HUT Positions ................................................... 46 
Figure 8. The Relationship Between SBP and SDMT Scores ...................................................... 47 
Figure 9. The Relationship Between SBP and Interference Scores .............................................. 48 
Figure 10. Cerebral Blood Flow Velocity during Baseline, Stroop Testing, and Head-up Tilt ... 66 
Figure 11. Cerebral Blood Flow Velocity during Baseline, SDMT Testing, and Head-up Tilt ... 67 
Figure 12. Cerebral Oxygen Saturation during Baseline, Stroop Testing, and Head-up Tilt ....... 69 
Figure 13. Cerebral Oxygen Saturation during Baseline, SDMT Testing, and Head-up Tilt....... 70 
Figure 14. Mean Arterial Pressure during Baseline, Stroop Testing and Head-up Tilt ................ 72 
Figure 15. Mean Arterial Pressure during Baseline, SDMT Testing and Head-up Tilt ............... 73 
 
 xii 
 
List of Appendices 
 
Appendix A. Copyright for Elsevier ............................................................................................. 86 
Appendix B. Montreal Cognitive Assessment .............................................................................. 87 
Appendix C. Symbol Digit Modalities Test ................................................................................. 88 
Appendix D. Stroop Colour-Word Test ........................................................................................ 89 
Appendix E. Research Ethics Approval Notice ............................................................................ 90 
 
 
 
 
 
 
 
 
 
 
 
 
 xiii 
 
List of Abbreviations 
 
AD 
AF 
Alzheimer’s disease 
Autonomic failure 
ANS 
ARS 
Autonomic nervous system 
Autonomic reflex screen 
BMI Body mass index 
BP Blood pressure 
bpm 
CBFv 
Beats per minute 
Cerebral blood flow velocity 
CON Control subject 
DBP Diastolic blood pressure  
HR Heart rate 
HRDB 
IPS 
Heart rate deep breathing  
Information processing speed  
HUT Head-up tilt  
LBD 
MAP 
MCI 
Lewy body dementia 
Mean arterial pressure 
Mild cognitive impairment  
mmHg Milliliters of mercury 
 xiv 
 
MMSE Mini-mental state examination  
MoCA Montreal cognitive assessment 
MS Multiple sclerosis  
MSA 
NIRS 
Multiple system atrophy  
Near infrared spectroscopy 
NOH Neurogenic orthostatic hypotension 
OH Orthostatic hypotension 
PAF Pure autonomic failure  
PD Parkinson’s disease 
PFC Prefrontal cortex 
PNS Parasympathetic nervous system  
QSART 
rSO2 
Quantitative sudomotor axon reflex test 
Regional cerebral oxygen saturation 
SBP  Systolic blood pressure 
SDMT Symbol digit modalities test 
SNS 
TCD 
Sympathetic nervous system  
Transcranial doppler 
VM Valsalva maneuver 
VR Valsalva ratio 
  
 1 
 
Chapter 1 
 
1 Introduction 
It is common knowledge that cognitive decline is a natural process of aging 1. Aging causes a 
decrease in many cognitive domains including memory, spatial visualization, information 
processing speed (IPS), attention, executive functioning, and conceptual reasoning1,2. Reduced IPS 
can be especially problematic since it is a predictor of the ability to perform simple daily activities 
and an indicator of independence 3,4. Cognitive decline can occur at an accelerated rate in 
neurodegenerative conditions like Alzheimer's disease (AD), Lewy-body dementia (LBD), 
Parkinson's disease (PD), and multiple sclerosis (MS) 5,6. There is limited literature on a 
neurological condition referred to as neurogenic orthostatic hypotension (NOH) and its 
relationship to cognitive decline. NOH is a cardinal feature of many neurodegenerative diseases 
such as Multiple System Atrophy (MSA), PD, LBD, and pure autonomic failure (PAF), therefore 
it could also be linked to accelerated cognitive decline.  
 
NOH is characterized by a drop in systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood 
pressure (DBP) ≥ 10mmHg in the absence of a compensatory increase in heart rate (HR) within 
three minutes of upright posture or head-up tilt (HUT). Autonomic nervous system damage can 
cause inadequate release of norepinephrine, from the sympathetic nerves therefore insufficient 
vasoconstriction occurs and results in a postural blood pressure (BP) drop. The severe drop in BP 
causes symptoms such as lightheadedness, dizziness, weakness, and fatigue. These symptoms 
make simple daily activities difficult to perform and can increase the risk of falls 7. 
 
Prior research has stated that this large drop in BP can provoke a reduction in cerebral blood flow 
8,9. This is problematic because cerebral hypoperfusion has been linked to cognitive decline 7,10. 
There is a variety of literature related to this topic but there is very little research specifically 
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related to NOH patients and cognitive decline. Determining if alterations in cerebral blood supply 
affect cognitive functioning in NOH patients will be an important addition to the current literature.  
Therefore, this thesis will provide general information about the autonomic nervous system and 
conditions and diseases related to autonomic dysfunction with an emphasis on NOH. 
Epidemiology, diagnostic testing, and treatment of NOH will be addressed in great detail. This 
thesis will also discuss how alterations in cerebral hemodynamics affect cognitive functioning, 
specifically IPS and attention. 
 
The first research study presented in this thesis aimed to investigate the potential changes in 
cognitive function experienced by individuals with NOH in both the supine and HUT positions. 
The study also aimed to describe the relationship between cognitive function and the change in 
SBP in NOH patients. The second study presented in this thesis assessed cerebral hemodynamics 
parameters including cerebral blood flow velocity (CBFv) and regional cerebral oxygen saturation 
(rSO2) in NOH patients in the supine and HUT positions. This study also aimed to determine the 
effects of cerebral hypoperfusion on IPS and attention. 
 
Accordingly, the following hypotheses were made: 
1. NOH patients will experience a decline in IPS and attention in the HUT position compared 
to the supine position due to the associated reduction in postural BP. Controls will 
experience an increase in IPS and attention in the HUT position compared to supine. 
2. The magnitude of the postural SBP drop will correspond with a worsening in IPS and 
attention. Therefore, the larger the drop in SBP, the worse the NOH patients will perform 
on the cognitive tests. 
3. NOH patients will have a reduction in CBFv and rSO2 in the HUT position compared to 
the supine position, whereas controls will experience no changes in CBFv and rSO2 with 
the change in position. 
4. The reduced measures of CBFv and rSO2 may be related to a decline in IPS and attention. 
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Chapter 2 
 
2 Literature Review  
 
2.1 Autonomic Nervous System  
The autonomic nervous system (ANS) unconsciously provides neural control to regulate bodily 
functions such as heart rate, blood pressure, sweating, respiration, gastrointestinal motility, urinary 
and bowel excretion, and reproduction. The ANS maintains homeostasis through the coordinated 
control of all bodily functions 11. This system is composed of three main divisions; the sympathetic 
nervous system (SNS), the parasympathetic nervous system (PNS), and the enteric nervous system. 
This thesis will only focus on the SNS and PNS, which are displayed in Figure 1. The SNS and 
PNS have antagonistic effects; the SNS works to increase bodily functions such as HR, breathing, 
sweating, and constricts blood vessels, whereas the PNS is used to slow these high energy 
functions during times of rest and digestion. Therefore, these systems work together to ensure the 
balance of homeostasis.  
 
The SNS originates in the spinal cord, specifically in the lateral grey column of T1 to L1-2 11. A 
preganglionic efferent neuron exits the spinal column, synapses at a ganglion, and then continues 
as a postganglionic neuron. Postganglionic neurons innervate target organs such as the eyes, heart, 
lungs, stomach, intestines, bladder, sweat glands, reproductive organs, and kidneys. In the SNS 
the preganglionic neurons are relatively short and are cholinergic releasing acetylcholine whereas 
the postganglionic fibers are fairly long and are noradrenergic releasing norepinephrine. The 
primary neurotransmitter of the SNS is  norepinephrine and when released it stimulates the body  
during times of increased activity 12,13.  
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The PNS originates in two primary areas. Firstly, the cranial nerves III, VII, and IX which arise in 
the cranium and then synapse with a ganglia before going to their target tissues, as well as the 
vagus nerve (cranial nerve X) which originates in the medulla oblongata and controls the heart, 
lungs and the digestive tract 11. Secondly, cell bodies in the lateral grey horn of the spinal cord at 
the level of T12-L1, which then exit the spinal cord at S2-S4. The preganglionic neurons release 
acetylcholine at both the ganglion synapses and the postsynaptic terminals 12. Postganglionic fibres 
in the PNS are shorter than in the SNS. This system acts to slow bodily functions and is primarily 
used during times of rest and digestion.  
 
The SNS and PNS function primarily through autonomic reflexes. The baroreflex is extremely 
important in the control of regulating arterial BP 11. The receptors responsible for measuring 
changes in BP are found in the aortic arch and the carotid sinus. These receptors relay information 
to the central nervous system. When BP decreases the baroreceptors are activated and cause an 
increase in excitatory input to the preganglionic sympathetic neurons, which in turn produces an 
increase in BP. This type of reflex is activated anytime BP drops, for example when an individual 
stands up. Together these two systems function to control most involuntary mechanisms and work 
to maintain homeostasis of the body 11.  
 
Multiple studies have demonstrated that the PNS and the SNS are involved in cognitive 
functioning 14,15. The PNS is responsible for regulating high frequency heart rate variability which 
was associated with greater inhibitory cognitive control  during the Eriksen flanker task in a study 
of 56 participants 15. A study found that individuals with greater hear rate variability had better 
executive function than individuals with low heart rate variability. A link has been found between 
the performance of a cognitive task and an increase in SNS activation 14. Therefore, damage to the 
PNS or the SNS may result in altered cognitive functioning. 
 
 
 5 
 
 
 
Figure 1. The Autonomic Nervous System 13 
This diagram displays both the sympathetic and parasympathetic divisions of the ANS. The SNS 
originates at T1-L2 and the PNS originates at CN III, VII, IX, and X and S2-S4. Each division 
innervates specific target organs. 
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2.2 Autonomic Dysfunction 
Any main system of the human body can suffer from dysfunction including the ANS. Damage to 
the ANS can occur from an autoimmune disease, diabetes, an infection, a side effect of medication, 
an abnormal protein buildup, or an inherited disorder 16. Nerve damage interferes with the signals 
communicating between the brain and the effector organ. Consequently, severe symptoms can 
arise in the presence of autonomic dysfunction since the ANS controls many vital bodily functions. 
Autonomic dysfunction can present with a variety of symptoms, including irregularities with 
sweating, inability to regulate heart rate, lightheadedness, dizziness, weakness, fatigue, urinary 
problems, sexual dysfunction, and digestive issues. A common and debilitating symptom referred 
to as orthostatic hypotension (OH) can occur in individuals with autonomic dysfunction. OH is 
characterized by a profound drop in systolic blood pressure (SBP) of ≥ 20mmHg or diastolic blood 
pressure (DBP) of ≥ 10mmHg within three minutes of upright posture. OH can be triggered by 
either a nonneurogenic or a neurogenic cause. Nonneurogenic OH can be caused by hypovolemia, 
cardiac pump failure, venous pooling and some medications 17. Nonneurogenic OH can sometimes 
be resolved by increasing fluid intake, increasing salt intake, wearing compression stockings or an 
abdominal binder. Neurogenic orthostatic hypotension usually has no cure and often results from 
permanent damage to the ANS. 
 
A large array of diseases and disorders are related to autonomic dysfunction. Some common 
conditions include Parkinson’s disease (PD), lewy body dementia (LBD), pure autonomic failure 
(PAF), multiple systems atrophy (MSA), primary amyloidosis and diabetic neuropathy. These 
diseases present with different clinical features, for example PD can present with a tremor, LBD 
can present with cognitive problems, but most will also present with the symptom of OH.  
Autonomic dysfunction develops early in patients with MSA, PAF and LBD thus OH is normally 
the most prominent clinical feature. Parkinson’s disease can also present with autonomic 
dysfunction, but it normally presents later in the disease. Up to 58% of PD patients will experience 
autonomic failure 18 .  
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2.3 Neurogenic Orthostatic Hypotension (NOH) 
Neurogenic orthostatic hypotension (NOH) is a hallmark feature of autonomic failure 19. NOH 
occurs secondary to either neuropathy of the peripheral nervous system or to a central nervous 
system lesion 20. It is most commonly found in the elderly population 21. NOH is characterized by 
a severe drop in systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥ 
10mmHg within three minutes of standing up or HUT 22.  
 
NOH is associated with autonomic degenerative disorders such as PD, MSA, LBD, and PAF. It is 
also associated with peripheral neuropathies such as Guillain Barre syndrome, diabetic neuropathy, 
hereditary amyloidosis, and familial dysautonomia 21. NOH is a common symptom related to these 
diseases since BP regulation is often affected when the ANS is damaged. 
 
When a healthy individual changes position from sitting to standing, the effect of gravity causes a 
shift of approximately 500-1000ml of blood into the lower extremities 23. Pooling of blood in the 
lower body results in decreased venous return, which causes decreased cardiac output and a 
reduction in postural BP. The baroreflex response then acts to increase peripheral resistance, 
venous return to the heart and cardiac output 23. Consequently, there is very little change in 
systemic BP since the baroreflex activation is immediate. Individuals with NOH have an impaired 
BP and HR response to standing due to baroreflex failure. The sympathetic vasomotor neurons do 
not release an adequate amount of norepinephrine to produce suitable peripheral vasoconstriction. 
Without vasoconstriction blood pools in the lower extremities resulting in a BP drop 21.  
 
NOH patients experience a variety of symptoms during an orthostatic challenge; the most common 
being lightheadedness, dizziness, weakness, fatigue, and difficulty thinking. Symptoms tend to 
worsen with specific stressors. These stressors include; standing up in the morning after being 
supine for a long duration, hot weather/ hot shower or bath which cause cutaneous vasodilatation, 
after eating a large meal which causes splanchnic vasodilatation, during prolonged standing which 
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can cause BP to continually decease, coughing since it increases intrathoracic pressure which 
further decreases venous return to heart 24. Symptomatic NOH can be severely disabling, increase 
the risk for injurious falls, and decrease quality of life 25.  
 
2.4 Diagnostic Tests for NOH 
When diagnosing NOH, a clinician will take into consideration a medical history, neurological 
examination and a standardized autonomic reflect screen (ARS). The ARS is a validated tool that 
consists of four tests which assess the integrity of the ANS 26. The function of both the sympathetic 
and parasympathetic nervous system can be evaluated using the ARS. Each test is described in 
depth below.  
 
2.4.1 Quantitative Sudomotor Axon Reflex Test (QSART) 
The human sweat glands are regulated by postganglionic sympathetic sudomotor axons 27. When 
acetylcholine is released from the axon terminals it causes a sweat response to occur. QSART 
assesses the sweat function of four postganglionic nerves; ulnar, peroneal, saphenous and sural. A 
multicompartmental sweat cell is placed over each one of the four nerves and secured in place with 
a rubber strap. Ground electrodes are positioned beside each sweat cell. The placement of each 
sweat cell is as follows; forearm between the ulnar epicondyle and the pisiform bone, proximal leg 
5 cm distal to the fibular head, distal leg 5 cm proximal to the medial malleolus, and dorsum of 
the foot over the extensor digitorum brevis muscle 28. The sweat cell has an outer ring where the 
acetylcholine gel is located and an inner compartment from which the sweat response is recorded.  
Five minutes of constant anodal current iontophoresis of 10% acetylcholine at an intensity of 2mA 
is used to stimulate the sudomotor axons. The 2mA current causes the release of the acetylcholine 
from the multicompartmental sweat cell, which activates the sweat response. After the stimulation 
is turned off an additional five minutes is recorded. Sweat volumes are recorded for the total 
duration of the test.  
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A normal test (Figure 2A) displays sweat volumes above the lower limit which is as follows 0.122, 
0.160, 0.079, and 0.102uL for forearm, proximal leg, distal leg, and foot respectively. Whereas, 
irregular tests (Figure 2B) can show significantly reduced (i.e. hypohidrosis) or increased (i.e. 
hyperhidrosis) sweat volumes. Individuals with peripheral neuropathy are likely to have a length 
dependent reduction in sweat volumes, thus the most reduced volumes are located the most 
distally. Irregular test results can indicate damage to the postganglionic axons in the SNS  26.  
 
 
 
 
Figure 2. QSART in A) Healthy Individual and B) NOH Patient 
Each line represents one of the 4 sites tested. Red line: forearm, blue line: proximal leg, green line: 
distal leg, and yellow line: foot. The purple arrows indicate when the electrical stimulation started 
and ended. Graph A shows a normal response to QSART, whereas graph B shows reduced sweat 
volumes in a patient with NOH. 
A) 
B) 
Healthy Individual 
NOH Patient 
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2.4.2 Heart Rate Variability to Deep Breathing 
A deep breathing exercise can be used to assess cardiovagal function 26. A breathing frequency of 
five seconds inspiration and five seconds expiration is used for eight consecutive cycles. To 
accurately achieve this breathing frequency slow deep breaths are completed following a column 
of green light, breathing in as the light goes up the column and breathing out as the green light is 
going down the column. HR is recorded during this test to measure HR variability which analyzes 
parasympathetic function.  
 
In a healthy individual HR should increase during inspiration and decrease during expiration, 
therefore large fluctuations in HR should occur with deep breathing, this can be seen in Figure 3A. 
The lower limit for HR difference during deep breathing is 4.8bpm for males and 6.2bpm for 
females. Impaired cardiovagal function is indicated by a HR variability below the lower limit.  
NOH patients are a group of individuals who show very little HR variability during this test, 
suggesting cardiovagal impairment, which can be seen in Figure 3B.  
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Figure 3. Deep Breathing Task in A) Healthy Individual and B) NOH Patient 
The deep breathing task is performed two times with a one-minute rest period between trials, the 
start and end of each trial are indicated by the markers at the bottom of the graph. Graph A shows 
large fluctuations in HR during deep breathing, whereas graph B shows almost no change in HR 
during deep breathing.  
A) 
B) 
Healthy Individual 
NOH Patient 
HR 
HR 
SBP 
SBP 
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2.4.3 Valsalva Maneuver  
The Valsalva maneuver (VM) is used to calculate a Valsalva ratio (VR) which is the maximum 
HR achieved during the VM divided by the minimum HR occurring within 30 seconds of the 
maximum HR. The maneuver requires the participant to blow into a mouthpiece to a pressure of 
40mmHg and hold it at this pressure for 15 seconds. The maneuver produces a cascade of events; 
there is a change in intrathoracic pressure which decreases venous return, there is a drop in BP, 
activation of baroreflex, reflex tachycardia, and peripheral vasoconstriction 13. Monitoring beat-
to-beat BP changes during the maneuver allows for evaluation of the baroreflex function. The 
lower limit of normal for the VR in males is 1.31 and in females is 1.3. If the VR is below this 
limit, it can indicate impairment of cardiovagal function. 
 
In a healthy individual the beat-to-beat BP response to this maneuver shows four distinct phases, 
which are as follows: Phase I demonstrates an increase in BP due to increased intrathoracic and 
intra-abdominal pressure which causes compression on the aorta, which reduces venous return. 
Early Phase II shows a drop in BP due to the reduced venous return. This drop in BP activates 
baroreflexes. Late Phase II shows an increase in BP back towards baseline BP (alpha-adrenergic). 
Phase III occurs due to decreased in intrathoracic pressure, therefore BP decreases causing a burst 
of sympathetic activity. Phase IV is represented by an overshoot in BP (beta-adrenergic) 13. 
Following this maneuver, the time it takes for both BP and HR return to resting values is measured. 
This response is displayed in Figure 4A. 
 
Individuals with NOH show a different beat-to-beat BP response to this maneuver, which is 
displayed in Figure 4B. The beat-to-beat BP recording displays absent late phase II indicating an 
impaired baroreflex response, therefore BP continues to drop. Phase IV overshoot is also absent 
because there is no burst in sympathetic activity to cause a rapid increase in BP. Since NOH 
patients experience very little change in HR during the VM a low VR will result.  
 13 
 
 
 
Figure 4. Valsalva Maneuver in A) Healthy Individual and B) NOH Patient 
The Valsalva maneuver (VM) is performed two times, indicated by the markers at the bottom of 
the graph. Graph A shows all 4 distinct phases of the VM and a large increase in HR, whereas 
graph B shows an absent late phase II and phase IV overshoot and very little change in HR. 
A) 
B) 
Healthy Individual 
NOH Patient 
SBP 
SBP 
HR 
HR 
 14 
 
2.4.4 Head-Up Tilt  
Head-up tilt (HUT) is one of the most important tests when diagnosing NOH. HUT assesses 
adrenergic function during an orthostatic challenge. The patient is positioned on a tilt table in the 
supine position with their feet flat against a footboard. HR is measured using an 
electrocardiography device and BP is measured with a beat-to-beat BP monitor. These measures 
are recorded in the supine position for one minute to determine resting HR and BP. Following one-
minute baseline, the bed is tilted to 70 degrees upright and remains in this position for five minutes, 
the table is then tilted back down to the supine position and an additional five minutes of recovery 
is recorded 26.  
 
This test simulates standing and allows the natural force of gravity to act on the body which causes 
a shift of blood volume into the lower limbs. A healthy individual will have very little change in 
BP and HR during HUT since the ANS activates a response to increase vasoconstriction which 
maintains BP at a normal level, which can be seen in Figure 5A. If a slight drop in BP occurs 
during HUT HR will increase slightly to compensate for the BP decrease. 
 
Individuals with NOH experience a significant drop in BP within 2-3 minutes of HUT (Figure 5B). 
BP will drop at least 20/10mmHg with little to no change in baseline HR. This large drop in BP 
with no compensatory postural tachycardia indicates autonomic dysfunction. Damage to the 
sympathetic nerves causes insufficient vasoconstriction therefore, blood continues to pool in the 
lower extremities. Consequently, BP remains reduced for the whole duration of an orthostatic 
challenge. When standing, some patients feel severe symptoms of lightheadedness, dizziness, 
weakness, and/or fatigue, whereas some patients are asymptomatic. Symptoms are often dependent 
upon how large the drop in BP is and if the patient’s body has adapted to this drop. When the tilt 
table is returned to the supine position BP will increase back to baseline. 
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Figure 5. Head-up Tilt in A) Healthy Individual and B) NOH Patient 
Initiation of head-up tilt occurs at the first marker at the bottom of the graph and the table is 
returned to the supine position at the second marker. Graph A shows very little change in SBP and 
a slight increase in HR during HUT, whereas graph B shows a severe drop in SBP and a very small 
change in HR during HUT.   
A) 
B) NOH Patient 
Healthy Individual 
SBP 
SBP 
HR 
HR 
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2.5 Treatment of NOH  
There is currently no cure for NOH, therefore treatment can be used to reduce the associated 
symptoms. Decreasing the occurrence of symptoms improves the quality of life of the patients. 
Both non-pharmacological and pharmacological interventions can be used to help treat symptoms. 
 
2.5.1 Non-pharmacological Treatment  
Non-pharmacological interventions can be used to reduce the occurrence and severity of symptoms 
associated with low BP. Both increased fluid intake and increased salt intake can help raise overall 
BP. It has been advised that NOH patients should consume 2 to 2.5 L of water per day 17. During 
activities in the upright position wearing an abdominal binder can assist in increasing venous return 
which may reduce the drop in BP. Patients should be instructed to consume small meals since large 
meals containing a high carbohydrate content cause splanchnic vasodilatation. Activities that raise 
core body temperature should be avoided such as exercising on hot days, hot showers/baths, and 
saunas since they cause skin vasodilatation and NOH patients have impaired vasoconstriction. If 
safe, patients should be instructed to complete lower body strength training, this will help maintain 
lower limb muscle pumps to push blood back to the heart it will also prevent deconditioning. 
Patients should be instructed to avoid straining and coughing since these maneuvers cause a drop 
in BP. To ensure BP is not too high when lying down the head of the bed should be tilted up when 
sleeping. These simple strategies can help reduce the burden of symptoms 29. If these non-
pharmacological measures do not improve symptoms pharmacological measures can be 
implemented.  
 
2.5.2 Pharmacological Treatment  
Pharmacological treatments are implemented to increase BP during times of low BP. 
Florocortisone is used at a dose of 0.05 to 0.2 mg daily to help retain sodium and water 24. 
Midodrine is an α1 agonist used at a dose of 2.5 to 5 mg once to twice daily to induce 
vasoconstriction 23. Pyridostigmine can be used with a  dose of 60 mg twice to three times per day 
or long acting forms 180 mg daily 28. Pyridostigmine inhibits acetylcholinesterase in preganglionic 
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sympathetic neurons therefore increasing sympathetic traffic 24. It also has a much milder affect 
on BP than midodrine and fludrocortisone.  
 
2.6 Cerebral Hemodynamics 
Monitoring cerebral hemodynamics in healthy individuals gives insight about natural cerebral 
blood flow changes that occur with aging. Between the ages of 20-70 there is a continual decline 
in cerebral blood flow velocity (CBFv) in the basal arteries 30.  Aging affects both cerebral blood 
flow and cerebral vasculature 31. Cerebral autoregulation is a mechanism used to ensure the brain 
is receiving adequate blood supply despite changes in systemic BP 32. This mechanism works by 
rapidly adjusting cerebrovascular resistance and compensating for fluctuations in cerebral 
perfusion pressure 33. It is a protective mechanism and prevents against brain ischemia when BP 
is low and capillary damage when BP is high 34.  Severe changes in BP can cause disruption to 
cerebral blood flow if SBP is outside of the autoregulation range (approximately ~80-160mmHg 
in healthy individuals) 35. NOH patients experience significant fluctuations in SBP, therefore it is 
important to identify if they have alterations in cerebral blood supply. Common techniques used 
to measure cerebral blood supply are transcranial doppler and near infrared spectroscopy.  
 
2.7 Transcranial Doppler 
Transcranial Doppler (TCD) is a non-invasive ultrasound technique used to measure real-time 
cerebral blood flow velocity (CBFv). TCD emits ultrasound waves from a probe at a frequency of 
2MHz which penetrate through the skull and are reflected by moving red blood cells 36. A term 
referred to as the Doppler shift frequency is the difference in frequency between the emitted and 
reflected waves, which is proportional to the speed of moving red blood cells 36. The middle 
cerebral artery (MCA) is commonly used to measure CBFv since it is found near a thin region of 
the skull referred to as the transtemporal window where the ultrasound waves can easily penetrate 
through the skull. The MCA can be found with the probe set to a depth between 45 to 55mm. TCD 
also measures pulsatility index, which provides information about the downstream cerebral 
vascular resistance 37. The pulsatility index is normally between 0.5 to 1.19  37. A limitation of 
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TCD is that measures can not be obtained in about 10-15% of people. This occurs when individuals 
have an inadequate transtemporal window due to the thickness and porosity of the bone near the 
window 36. The following formula describes the relationship between flow velocity (reflector 
speed)  and Doppler shift frequency  36:  𝑅𝑒𝑓𝑙𝑒𝑐𝑡𝑜𝑟 𝑠𝑝𝑒𝑒𝑑 (
𝑐𝑚
𝑠
) =  
(𝑑𝑜𝑝𝑝𝑙𝑒𝑟 𝑠ℎ𝑖𝑓𝑡)𝑋 𝑝𝑟𝑜𝑝𝑎𝑔𝑎𝑡𝑖𝑜𝑛 𝑠𝑝𝑒𝑒𝑑
2 𝑋 𝑖𝑛𝑐𝑖𝑑𝑒𝑛𝑡 𝑓𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑋 𝑐𝑜𝑠𝜃  
  
 
The doppler shift is the change in frequency of a wave in relation to an observer who is moving 
relative to the wave source. The propagation speed is the speed of ultrasound in the tissue. The 
incident frequency is the original frequency of the ultrasound. Theta (θ) is the angle of the emitted 
wave relative to the direction of blood flow in the vessel 36.  
 
The application of TCD can be used to monitor a variety of conditions such as vasospasm in sickle 
cell disease, raised intracranial pressure, head injuries, subarachnoid hemorrhage, intra- and 
extracranial arterial stenosis and occlusion, and intraoperative monitoring 37. Monitoring CBFv 
can provide important information about the clinical conditions listed. Alterations in CBFv also 
occur when there are drastic changes in systemic BP 9. Accordingly, it is beneficial to measure 
CBFv in NOH patients since they are a population who experience large fluctuations in BP. 
 
2.8 Near Infrared Spectroscopy 
Near infrared spectroscopy (NIRS) is a non-invasive technique used to measure regional cerebral 
oxygen saturation (rSO2) using light wavelengths between 700-1000nm. NIRS is placed bilaterally 
on the forehead to measure rSO2 in the frontal lobes. The wavelengths are able to pass through the 
skull to reach the cortical tissue 38. Oxygen uptake is calculated by the difference in oxyhemoglobin 
and deoxyhemoglobin. rSO2 provides insight about the oxygen supply the brain is receiving. 
Normal rSO2 values range from 60-80% 
39.  
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rSO2 will vary depending on how much oxygen the brain requires. rSO2 increases when the 
metabolic activity of neurons rises so that the metabolic demands can be met  40. For example, 
when a brain region is functionally activated there will be an increased metabolic demand. A 
decrease in systemic BP has been linked to a decrease in rSO2. A decrease in blood flow can affect 
oxygen delivery to the brain tissues being measured 39. Therefore, rSO2 should be monitored in 
patients with NOH.  
 
2.9 Cerebral Hemodynamics &Autonomic Dysfunction  
Adequate cerebral blood supply is important for physical and cognitive functioning. Monitoring 
cerebral hemodynamics in patients with autonomic dysfunction is beneficial to determine if the 
brain is receiving an adequate blood supply since this population can suffer from cerebral 
hypoperfusion. Substantial evidence suggests that cerebral hypoperfusion contributes to cognitive 
dysfunction 41. Multiple studies have assessed cerebral hemodynamics in patients with autonomic 
dysfunction but the mechanisms altering cerebral perfusion are not completely understood 42.  
 
As mentioned individuals with autonomic dysfunction lack the ability to control vascular tone 
when standing, therefore they are unable to increase systemic vascular resistance 43. Consequently, 
blood supply to the brain may be reduced in the upright position. Multiple studies have assessed 
cerebral hemodynamics in both the supine and standing positions in patients with autonomic 
dysfunction 32,43,44. A prior study assessed 8 patients with PAF and 1 patient with MSA who 
experienced a significant decrease in BP upon standing. Findings demonstrated that supine CBFv 
was higher in patients than controls and upon standing CBFv decreased significantly in the patient 
group. In the standing position rSO2 also decreased more in the patient group than the controls 
43. 
A separate study assessing cerebral hemodynamics in 7 MSA patients and 9 controls found that 
during HUT, MSA patients had a greater decrease in mean arterial pressure (MAP) at the level of 
the skull than controls. During HUT, there was also a reduction in cerebral oxygenation in MSA 
patients and controls, but no significant difference between groups 32. Cerebral oxygenation was 
investigated in 18 patients with autonomic failure (AF) and 10 healthy controls in both the supine 
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and HUT positions. Results demonstrated that during HUT, MAP increased in the controls by 
12.3mmHg and decreased in the patients by -46.7mmHg. During HUT, the control group had a 
small reduction in rSO2 by -0.5% whereas the patient group had a significant decrease by -8.5% 
44. These studies revealed that an orthostatic stress can cause a reduction in CBFv and rSO2 in 
patients with autonomic dysfunction. 
 
When assessing rSO2 in 19 MSA patients and 10 healthy controls it was found that during HUT 
presyncopal patients experienced a significantly larger decrease in rSO2 (-3.1 ± 1.7%) than non 
pre-syncopal patients (-0.9 ± 0.5%) and controls (-1.1 ± 1.0%). These results demonstrated that 
the reduction in rSO2 was related to orthostatic symptoms. During HUT most of the presyncopal 
MSA patients had SBP readings below 80mmHg and had rSO2 values below 70%. Accordingly, 
when SBP is extremely low, cerebral autoregulation may not be as effective 8. Patients are more 
likely to experience symptoms when they are outside the autoregulated range of 80-160mmHg 35. 
When BP drops individuals with PAF exhibited symptoms of cerebral hypoperfusion. These 
individuals had reduced rSO2 measures compared to controls 
45. Cerebral blood flow was 
investigated in 7 women with OH. During HUT, there was a decrease in mean hemispheric blood 
flow compared to supine. During HUT, there was also a redistribution of blood flow, with an 
increase in the postcentral areas and a decrease in the frontal area 46. It is evident that changes in 
both CBFv and rSO2 occur in patients with autonomic dysfunction during an orthostatic challenge 
due to a postural reduction in systemic BP. Even in healthy individuals a drop in cerebral perfusion 
has been identified upon standing since cerebral autoregulation is unable to immediately 
compensate for the initial drop in BP that results from the gravitational blood pooling upon 
standing 47. This decrease in rSO2 is extremely short lived and lasts for only seconds in healthy 
individuals. Whereas, NOH patients can have a reduction in rSO2 that lasts the entire duration of 
standing.  
 
Literature specifically related to NOH patients and changes in cerebral blood flow is limited. A 
study revealed that in the standing position NOH patients had transient cerebral hypoperfusion and 
upon returning to the supine position cerebral blood flow returned to normal 48. Consequently, 
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continuous exposure to repeated cerebral hypoperfusion may endure brain changes that could lead 
to accelerated cognitive decline 48,49. Prior research has speculated a link between cerebral 
hypoperfusion and deficits in short-term memory, abstract thinking, visual memory, and  attention 
50. There are few studies specifically related to patients who experience cerebral hypoperfusion 
and how it could be related to changes in cognitive function, therefore further investigation on this 
topic is necessary. 
 
2.10  Normal Aging and Cognitive Decline 
The process of natural aging causes changes in brain structure including a reduction in total brain 
volume 31, cortical thinning, white-matter degradation 51, and alterations in synaptic connectivity 
52. Brain volume decreases by about 5% per decade after the age of 50 53, particularly the frontal 
lobes 31. A review examining MRI scans found that prefrontal cortex (PFC) volume had the 
greatest atrophy in older adults 53. The PFC is also affected by molecular changes which correlate 
with aging 54.  MRI can be used to measure the thickness of the cerebral cortex to investigate 
cortical thinning. Studies have found that cortical thinning occurs by middle age and affects a 
widespread cortical area that continues to thin with aging 55. White matter loss also occurs with 
aging. The development of white matter hyperintensities and hippocampal volume loss are a 
natural process of aging 56. A study investigating rhesus monkeys found that aging causes a 
significant overall loss of synapses in prefrontal area 46 57. These alterations in brain structure 
have been related to an increased rate of cognitive decline. The aging brain has differences in both 
structure and function which are associated with cognitive decline 51.  
 
These structural changes related to aging come with severe consequences to cognitive function. 
Aging is associated with a decline in memory, spatial visualization, information processing speed, 
attention, executive functioning, and conceptual reasoning 1,2. As previously mentioned, aging 
causes PFC atrophy. The PFC is one of the most important areas involved in cognitive control and 
is responsible for executive functioning 58. The PFC is heavily relied upon to accurately perform 
cognitive tasks such as the Stroop test which involves selective attention 59.  
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2.11  Cognitive Decline Associated with Disease  
Some diseases and conditions are associated with decreased cognitive functioning. Alzheimer's 
disease (AD) and LBD accelerate the progression of brain atrophy and cognitive decline 60. 
Individuals with AD experience the fastest rate of decline in attention, visuo-spatial and executive 
functions compared to other cognitive functions 6. A stroke can also result in changes in cognitive 
function. A study investigating IPS post-stroke and its effect on cognitive function found that 
stroke patients performed significantly worse in all cognitive domains compared to healthy 
controls. Processing speed was significantly reduced in 90% of stroke patients demonstrated by 
poor Symbol Digit Modalities Test scores 61. Total white matter hyper-intensity volume is also 
significantly related to slower IPS 56. Traumatic brain injury can also result in decreased cognitive 
functioning. Patients who suffered from a traumatic brain injury had reduced IPS and attentional 
difficulties 62. A review found that long-term cognitive impairment occurred in about 50% of 
individuals with a single traumatic brain injury 63. A multitude of reasons can contribute to the 
accelerated rate of cognitive decline therefore, investigation is needed to determine exactly what 
is triggering the decline in cognitive functioning. It is important to be able to distinguish between 
normal cognitive decline and accelerated cognitive decline as a result of disease. 
 
Neurological diseases can affect important cognitive domains such as IPS and attention. IPS is a 
measure of the time between receiving a stimulus and responding to a stimulus 64. This type of 
processing is an essential component of cognitive functioning 2, 65. A decline in IPS can affect 
many cognitive domains, such as verbal fluency, attention, visuospatial function, memory, and 
executive function. Multiple sclerosis (MS) is a neurological disease that often presents with a 
decline in IPS.  This decline is one of the first cognitive deficits to surface in MS patients 66. A 
study used neuropsychological tests to assess IPS in MS patients during times of relapse and 
recovery. Results showed that during time of relapse MS patients had significantly worse SDMT 
scores indicating slower IPS 67. This finding is common among other studies investigating 
cognitive function in MS patients 68. If, IPS is reduced early in disease progression in MS patients, 
it may also be reduced early in other neurodegenerative conditions.  
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Cognitive performance has been assessed in individuals with mild cognitive impairment (MCI) 
and those with MCI and OH. The individuals with OH had reduced processing speed and visual 
working memory compared to the group without OH. It was found that a higher prevalence of OH 
was correlated with the severity of cognitive status 7. A cohort of 4690 participants aged 50 plus 
were examined to determine the relationship between supine hypertension, OH, and cognitive 
performance. Results revealed that individuals with supine hypertension combined with OH had 
poorer global cognition and executive function than individuals with only supine hypertension  69. 
A relationship between cognitive impairment and OH has also been established in patients with  
α-synucleinopathies which includes PD, LBD and MSA. It is believed that the presence of α-
synuclein could be contributing to both OH and cognitive impairment or the hypoperfusion 
resulting from OH is impairing cognition 5. 
 
2.12  Cognitive Function and its Relationship to NOH  
The prevalence of NOH increases with age and is commonly diagnosed in the elderly population 
which is also the population at risk for normal cognitive decline 21. Consequently, there may be a 
relationship between NOH and changes in cognitive function. NOH patients can suffer from ANS 
damage, hypotension, cerebral hypoperfusion and fatigue 70. These symptoms could be factors 
influencing the decline in cognitive functioning. Prior research has stated that NOH and cognitive 
decline could be related since the brain regions involved in both are responsible for cardiovascular 
autonomic processes and cognitive control 49. NOH patients frequently complain about difficulty 
concentrating and thinking 71. Consequently, cognitive function in NOH patients has been 
investigated in a variety of ways, including assessing cognitive function in the supine, sitting, and 
standing positions, as well as comparing cognitive function to healthy controls. 
 
Baseline cognitive function is evaluated in the seated position to ensure cognitive performance is 
not affected by a positional change in BP. Fourteen patients with PAF with a postural SBP drop 
of at least 20mmHg underwent neuropsychological assessment in the seated position. Patients 
presented with significant deficits in speed, attention and executive functioning. These deficits 
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were found in both patients with and without white matter lesions, therefore the lesion was not the 
only cause of cognitive impairment 72. In a sample of 5,963 individuals aged 50 plus, 6.3% had 
OH. Participants with OH had significantly worse global cognitive function, processing speed, 
sustained attention, and memory compared to participants without OH 73. Therefore, OH may be 
contributing to changes in cognitive functioning. 
 
Previous literature has demonstrated that OH causes an increased risk of developing cognitive 
impairment. At a 4 year follow up the incidence of cognitive impairment was significantly greater 
in OH individuals (23.7%) than a control group (9.2%) 74. OH patients who had a significant drop 
in SBP while standing had worse verbal memory, global cognition and scanning and tracking 
scores than those without OH 75. A study found that the prevalence of OH correlated with the 
severity of cognitive deficits. The group of individuals with OH and MCI presented with 
significantly reduced processing speed, working memory and executive functions 7.  
 
When assessing cognitive function during an orthostatic challenge such as HUT it was found that 
NOH patients experienced a significant drop in SBP of at least 20 mmHg and had significantly 
worse global and executive cognitive performances 76. A study assessed cognitive function in a 
variety of different positions in 12 patients with PAF or autoimmune autonomic neuropathy and 
12 control subjects. Findings revealed that in the seated position global cognitive function was 
preserved but during HUT the patients had a significant decrease in immediate memory, working 
memory, abstract thinking, and sustained attention compared to controls 77. Neuropsychological 
assessment was used to evaluate cognitive function in both the supine and HUT positions in 10 
NOH patients. During HUT, NOH patients experienced a significant worsening in executive 
functioning, including a decrease in global cognitive functioning and specific tasks compared to 
the supine position 78. Overall, a significant difference in cognitive function between the supine 
and HUT positions has found been found in patients who experience NOH.   
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2.13  Cognitive Tests 
There are many neuropsychological assessments available to evaluate cognitive function. When 
selecting which cognitive assessments to administer it is important to consider the population being 
assessed, length and ease of administration, established norms, and reliability of the assessment. 
Prior research has stated that a decline in IPS is one of the first cognitive deficits to surface in MS 
patients 66, therefore a reduction in IPS may arise early in other neurological conditions such as 
NOH. Individuals with NOH struggle to remain in the standing position for an extended period of 
time since BP drops in this position. Therefore, when selecting tests to assess cognitive function 
in this population it is important to ensure the tests are short in duration if assessing patients in the 
upright position.  
 
2.13.1 Symbol Digit Modalities Test 
The symbol digit modalities test (SDMT) is a paper based neuropsychological test used primarily 
to assess IPS. A sheet of paper has a key at the top with the numbers 1 to 9, each number has a 
corresponding symbol above. Beneath the key there are eight rows of symbols with each row 
consisting of 15 symbols 79. In the oral version, the participant has 90 seconds to say out loud what 
number correctly corresponds with each symbol. The number of correct responses and the number 
of errors are recorded.  
 
The SDMT is a validated test and is widely accepted as an accurate measure of IPS 80. The SDMT 
was originally administered in a written format where the participant would write down the 
corresponding number that matched with the symbol. The oral version of the SDMT is beneficial 
because it does not require motor movement, which is necessary for the written version. The oral 
SDMT displayed strong positive correlations (r = 0.78 to 0.82) with the written SDMT in healthy 
adults. The oral SDMT was proven to be reliable over multiple test-retest intervals over a 48-week 
period, had a test-retest reliability coefficient of 0.76 in healthy adults and had an excellent test-
retest reliability coefficient of 0.89 in a group of stroke patients 81–83. Therefore, the oral version 
is a reliable way to measure IPS. 
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It has been stated that the SDMT was the best test to predict cognitive impairment in a sample of 
MS patients. 75.4% of the patients were correctly classified 84. SDMT is significantly associated 
with age, gender, cultural background, and level of education 85, therefore, these variables need to 
be taken into consideration when analyzing SDMT scores. SDMT has been used to screen for and 
diagnose cognitive impairment in MS patients. Even a small change in SDMT score by 3-4 points 
is clinically meaningful 67. Another advantage of the SDMT is that it only takes about 5 minutes 
to complete the testing.  
 
2.13.2 Stroop Test  
The Stroop test is a neuropsychological test originally developed in 1935 by John Ridley Stroop 
to measure attention and response inhibition 86. It can measure how well an individual is able to 
inhibit a dominant response and respond to an unusual one 87. It has been regarded as a gold 
standard test to measure attention and is able to measure selective attention independently from 
processing speed 88,89. The Stroop test requires the completion of three subtests which are each 45 
seconds in duration. Each test is a sheet of paper containing 100 words of colours (i.e. blue, red, 
purple, brown, green). The participant is instructed to say out loud as many words as possible in 
the time given. The first subtest is referred to as the Word Stroop test (W). In this version the words 
of colours are written in black ink. The second subtest is referred to as the Colour Stroop test (C) 
and consists of words of colours written in the same colour of ink as the word. The participant 
must say out loud the colour of the ink. The third subtest is referred to as the Colour-Word Stroop 
test (CW). In this version the word of the colour and the colour of the ink that the word is printed 
in do not correspond. For example, the word may say blue but be printed in red ink. In this task 
the participant must say the colour of the ink and inhibit themselves from saying the word. The 
correct number of responses and the number of errors for each subtest are recorded. The W test 
and the C test are completed to obtain a baseline for comparison with the CW test. 
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The most important information that can be obtained from the Stroop test is Golden’s interference 
(Ig) score. The interference score represents the amount of delay the participant has in naming the 
colour of the ink since they must inhibit themselves from saying the word. The interference score 
can be calculated using the score achieved in the CW trial subtract a predicted colour-word (Pcw) 
score.  The CW score represents the amount of time it takes for an individual to identify the colour 
of the ink plus the amount of time it takes to suppress the reading the word. A predicted colour-
word score is calculated based on how many correct answers were scored in the C trail and the W 
trial. This gives an estimate of how well the participant should score on the CW version. The lower 
the interference score, the worse the attention. The following equations are required to calculate 
the Ig score:   𝑃𝑐𝑤 =
(𝑊𝑥 𝐶)
(𝑊+𝐶)
    𝐼𝑔 = 𝐶𝑊 − 𝑃𝑐𝑤 
 
2.14 Conclusion 
Current literature investigating NOH patients, cerebral hemodynamics, and cognitive functioning 
is limited, therefore future research related to this topic is necessary. When studying NOH patients, 
it is crucial to understand the physiology of the condition so that caution is taken when the patient 
is in the upright position. It is important to measure HR, BP, CBFv, and rSO2 in NOH patients 
since these measures can fluctuate with positional changes. As well, if testing cognitive function 
in the supine and upright positions it is imperative to select tests that are short in duration so they 
can be completed in the upright position.  
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Chapter 3 
 
3 Neurogenic orthostatic hypotension impairs information 
processing speed and attention 1 
 
3.1 Introduction 
Neurogenic orthostatic hypotension (NOH) is a condition characterized by a reduction in systolic 
blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥ 10mmHg within three 
minutes of upright posture 1. A sudden drop in BP can trigger symptoms such as lightheadedness, 
dizziness, weakness and fatigue soon after standing up. These symptoms make simple daily 
activities more challenging and increase the likelihood of falls 2.  
 
NOH commonly occurs in the elderly population 3. This population is also at an increased risk for 
cognitive decline; therefore, it is important to investigate if there is a relationship between NOH 
and changes in cognitive function. Current literature focusing on NOH and cognitive function 
investigates processing speed, attention, and executive function in the seated position but fails to 
investigate cognition in the standing position 4. However, standing may be the time at which 
impairment of cognitive function is the most severe due to associated hypotension. It is also the 
time that affected individuals are at greater risk for complications from NOH such as falls. 
 
It is well-known that with aging there are changes in cognitive function. Many cognitive abilities 
decline with aging such as memory, spatial visualization, attention, information processing speed, 
                                                 
1
 A version of this manuscript has been submitted for publication. Robinson, L., Kimpinski, K. Neurogenic 
orthostatic hypotension impairs information processing speed and attention. Physiology & Behavior. 2019. Under 
revision. 
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and conceptual reasoning 5,6. Attention is the ability to attend to specific stimuli while inhibiting 
attention to other stimuli, which is required for many everyday tasks 7. When an individual is 
unable to focus on the relevant stimuli, interference from the irrelevant stimuli occurs. Interference 
is commonly measured using the Stroop Test, where greater interference indicates worse attention. 
The amount of interference from irrelevant information increases with aging 8, therefore older 
individuals have a more difficult time inhibiting an undesired response. Information processing 
speed (IPS) is the time between receiving a stimulus and responding to a stimulus 9. A common 
neuropsychological test to measure IPS is the Symbol Digit Modalities Test (SDMT). IPS is linked 
to higher cognitive functions 10 and, therefore, a decline in processing speed can affect other 
cognitive domains. It has been stated that IPS is a predictor of the ability to perform simple daily 
activities 11 and an indicator of independence 12. It was found that IPS was the first cognitive deficit 
to surface in individuals with multiple sclerosis 13. Consequently, a deficit in IPS or attention may 
also arise early on in other neurological conditions, such as NOH.  
 
The objective of the current study was to investigate the potential changes in IPS and attention in 
NOH patients in both the supine and head-up tilt (HUT) positions. In addition, the study’s further 
objective was to describe the relationship between cognitive function and the potential change in 
SBP in NOH patients. 
 
It was hypothesized that NOH patients would experience a decline in IPS and attention in the HUT 
position compared to the supine position due to the associated reduction in postural BP. Controls 
would have an increase in IPS and attention in the HUT position compared to the supine position 
since they experience a burst of sympathetic activity when they stand up. It was also hypothesized 
that a greater drop in SBP during HUT would correspond with a worsening in IPS and attention.  
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3.2 Methods 
3.2.1 Participants 
The current study enrolled 43 participants including 23 participants with a diagnosis of NOH and 
20 healthy age-matched controls. The clinical diagnosis of NOH was provided by a neurologist 
after evaluating the autonomic reflex screen (ARS) and a medical history. The criteria for NOH 
was a drop in SBP ≥ 30 mmHg on HUT as it reduced the false positive rate from 5% to <1% when 
compared to the ≥ 20/10 mmHg SBP/DBP criteria 14. The conditions associated with NOH 
included Parkinson’s disease (n=12), multiple system atrophy (n=4), pure autonomic failure (n=1) 
and Lewy body dementia (n=1). Five participants had a diagnosis of idiopathic NOH. 
 
Participants were excluded from the study if they had a medical history of coronary artery disease, 
nerve damage in the peripheral nervous system, failure of other organ systems or diseases that 
could affect autonomic function, visual problems, or the inability to remain in the upright position 
for the duration of testing. All testing took place in the autonomic lab located at the University 
Hospital in London, Ontario. All participants provided written informed consent before being 
enrolled in the study. Ethical approval was obtained from the Health Science Research Ethics 
Board at Western University. 
 
3.2.2 Physiological Measures  
Testing began with a standardized autonomic reflex screen (ARS). The ARS is comprised of four 
tests; 1. quantitative sudomotor axon reflex test (QSART) to assess the quality of the 
postganglionic sympathetic sudomotor axons, 2. deep breathing to assess cardiovagal function, 3. 
Valsalva maneuver which allows for the calculation of a Valsalva ratio to assess cardiovagal and 
adrenergic function and 4. HUT (table tilted to 70 degrees), which measures heart rate (HR) and 
BP responses to an orthostatic challenge  to assess adrenergic function 15. 
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HR was measured using an electrocardiography device (Model 3000 Cardiac Trigger Monitor, 
IVY Biomedical Systems, Inc., Branford, CT) connected to electrocardiography electrodes 
(Ambu® Blue Sensor SP, Glen Burnie, MD). A beat-to-beat BP monitor (BMEYE Nexfin device, 
Amsterdam, Netherlands) was secured on the middle finger. All recordings were made using WR 
TestWorks TM software (WR Medical Electronics Co., Stillwater, MN). 
 
3.2.3 Cognitive Measures  
Cognitive function was assessed with two paper based neuropsychological tests; the oral version 
of the Symbol Digit Modalities Test (SDMT) and the Stroop test. SDMT was used to assess IPS. 
SDMT provides a key at the top of the page that has numbers 1 to 9 and each number corresponds 
with a symbol. Underneath the key there are 8 rows of symbols and each row consists of 15 
symbols. Each participant had 90 seconds to say aloud what number corresponds with each 
symbol. The correct number of responses and the number of errors were recorded.  
 
The Stroop test was used to measure attention. It consists of three different versions; each version 
is a sheet of paper containing 100 words of colours (i.e. blue, red, purple, brown, green). Each 
participant had 45 seconds to say aloud as many words as possible. The first version consists of 
words of colours written in black ink. The second version consists of the words of the colours 
printed in the same ink colour as the word. For example, the word “blue” is printed in blue ink. In 
the third version, the word and the ink colour that the word is printed in do not correspond. For 
example, the word “blue” could be printed in red ink. The participant must say the colour of the 
ink and inhibit themselves from saying the word. The number of correct responses and the number 
of errors were recorded for each version. The correct number of responses in each version was 
used to calculate Golden’s interference score which represents attention 16 
 
Prior to cognitive testing 90 seconds in the supine position was recorded to measure baseline HR 
and SBP. The order of cognitive testing in the supine position was as follows; SDMT, Stroop 1, 
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SDMT, Stroop 2, SDMT, Stroop 3, SDMT. The bed was then tilted to an angle of 70 degrees 
(HUT) and 90 seconds of HR and SBP were recorded in this position before beginning the 
cognitive testing. The order of the cognitive testing in the HUT position was as follows; Stroop 1, 
Stroop 2, Stroop 3, SDMT. The bed was then tilted back to the supine position and the participant 
completed 5 minutes of recovery to allow HR and BP to return to resting values.  
 
The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) 
were used to screen for significant pre-existing cognitive impairment. Both questionnaires are 
scored out of 30 points and assess a variety of cognitive functions such as visuospatial, executive, 
memory, attention, language, orientation, and delayed recall. A normal score on MMSE is a score 
≥ 24 and ≥ 26 on the MoCA. A score lower than these values indicates cognitive impairment.  
 
3.2.4 Statistical Analysis  
Independent t-tests were used to compare characteristics such as HR, BP, age, BMI, MMSE and 
MoCA scores between groups. A two-way mixed ANOVA was used to compared cognitive testing 
between NOH patients and controls in both the supine and HUT positions. A Bonferroni post hoc 
test was used to compare within group effects for both positions. Results are presented in mean ± 
SD. A minimum significance level of p < 0.05 was used. The statistical analysis was performed 
using SPSS statistics software, Version 25, Manufactured by International Business Management 
(IBM) Corporation. 
 
3.3 Results 
3.3.1 Participants 
A total of 40 participants completed the study, 20 control subjects and 20 NOH patients. Three 
NOH patients were excluded because they were unable to remain in the upright position for the 
duration of testing, consequently they were unable to complete the cognitive testing. Controls and 
 42 
 
NOH patients were matched based on age, BMI, and education level. The NOH group had fewer 
females and more males than the control group, but no significant differences were found based 
on gender. NOH patients had significantly lower MoCA and MMSE scores (Table 1).  
 
3.3.2 Hemodynamic Measurements  
Hemodynamic measures are presented in Table 2. Resting HR, resting SBP, and the change in HR 
were not statistically different between groups. NOH patients had significantly lower scores for 
heart rate variability during the deep breathing task and Valsalva ratio (VR) indicating cardiovagal 
impairment 17. The change in SBP during HUT was significantly different between groups. The 
drop in SBP during HUT was significantly greater in the NOH patients (-64.11 ± 18.96) compared 
to the control group (-5.69 ± 7.65).  
 
Table 1. Participant Characteristics  
 
Characteristic  Control  
(mean ± SD) 
NOH  
(mean ± SD) 
Age (years) 64.50 ± 9.25 69.55 ± 7.43 
Gender (F:M) 12:8 8:12 
BMI (kg/m2) 21.50 ± 2.51 22.02 ± 4.71 
Education Level (>high school) 16 13 
MMSE Score 29.80 ± 0.41 28.74 ± 1.37 * 
MoCA Score 28.60 ± 1.54 26.53 ± 2.37 * 
BMI: body mass index, MMSE: Mini Mental State Examination, MoCA: Montreal Cognitive 
Assessment. * Represents significant difference of p < 0.01 
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Table 2.  Physiological Characteristics 
 
Characteristic  Control  
(mean ± SD) 
NOH  
(mean ± SD) 
Resting HR (bpm) 69.49 ± 11.91 74.28 ± 12.85 
Change in HR during HUT (bpm) 15.04 ± 6.27 12.12 ± 8.60 
Resting SBP (mmHg) 128.12 ± 18.75 139.50 ± 23.72 
Change in SBP during HUT (mmHg) -5.69 ± 7.65 -64.11 ± 18.96 ** 
Heart Rate Variability (bpm) 14.47 ± 6.96 4.48 ± 2.67 ** 
Valsalva Ratio 1.74 ± 0.33 1.29 ± 0.18 ** 
HR: heart rate, SBP: systolic blood pressure, HUT: head-up tilt, bpm: beats per minute, mmHg: 
millimeters of mercury, ** Represents significant difference of p < 0.001 
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3.3.3 Symbol Digit Modalities Test Scores  
Mean SDMT scores in the supine and HUT positions are displayed in Figure 6. IPS was 
significantly slower in NOH patients in both the supine (p < 0.001) and HUT (p < 0.001) positions 
compared to controls. Controls had significantly faster IPS during HUT demonstrated by a mean 
SDMT score of 69.90 ± 12.02 compared to a supine score of 63.55 ± 9.96 (p < 0.001). Whereas, 
the NOH group had no statistical difference in IPS between the supine position 43.20 ± 15.26 and 
the HUT position 42.90 ± 14.33 (p = 0.77). 
 
3.3.4 Stroop Test Scores 
The mean interference scores calculated from the Stroop test are displayed in Figure 7. A more 
negative score represents worse attention, whereas a score closer to 0 represents better attention. 
Controls had significantly better attention during HUT (-8.68 ± 7.13) compared to the supine 
position (-14.01 ± 8.96; p <0.001). In contrast, NOH patients had no statistical difference in 
attention between the supine and HUT positions (p = 0.11).  During HUT, the mean interference 
score was significantly worse in NOH patients (-14.86 ± 8.96) compared to controls (-8.68 ± 7.13; 
p = 0.029). 
 
3.3.5 Correlation between Blood Pressure & Cognitive Testing 
Figure 8 shows no significant correlation between the change in SBP and SDMT score in NOH 
patients (r = 0.284; p = 0.225) or controls (r = 0.293; p = 0.21). Figure 9 shows no significant 
correlation between the change in SBP during HUT and interference score in NOH patients              
(r = -0.147; p = 0.573) or controls (r = 0.078; p = 0.745). NOH patients experienced a significant 
drop in SBP during HUT, but this drop did not relate to IPS or attention. 
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Figure 6. Mean SDMT Scores in the Supine and HUT Positions 
Information processing speed (IPS) is represented by the mean SDMT score. NOH patients had 
significantly slower IPS than controls in the supine and HUT positions. Controls had significantly 
faster IPS in the HUT position compared to supine. NOH: neurogenic orthostatic hypotension, 
CON: control, HUT: head-up tilt, SDMT: symbol digit modalities test; a: p < 0.001, between CON 
and NOH in the supine position; b: p < 0.001, between CON and NOH in the HUT position; c: p 
< 0.001, between supine and HUT position in CON. 
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Figure 7. Stroop Test Scores in the Supine and HUT Positions 
The Stroop test provides a mean interference score which represents attention. An interference 
score closer to 0 represents better attention whereas a more negative score represents worse 
attention. Controls had better attention in the HUT position compared to supine. NOH patients had 
significantly worse attention in the HUT position compared to controls. NOH: neurogenic 
orthostatic hypotension, CON: control, HUT: head-up tilt; a: p < 0.001, between supine and HUT 
positions in CON; b: p = 0.029, between CON and NOH in HUT position. 
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SDMT Score 
 
 
 
Figure 8. The Relationship Between SBP and SDMT Scores 
 
There was no significant correlation between the change in SBP and SDMT score in NOH patients 
(p = 0.225) or controls (p = 0.21). NOH: neurogenic orthostatic hypotension, CON: control, HUT: 
head-up tilt, SDMT: symbol digit modalities test. 
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Interference Score 
 
 
 
Figure 9. The Relationship Between SBP and Interference Scores 
 
No significant correlation was found between the change in SBP and interference scores in NOH 
patients (p = 0.573) or controls (p = 0.745). NOH: neurogenic orthostatic hypotension, CON: 
control, HUT: head-up tilt.  
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3.3.6 MMSE and MoCA Scores 
An additional analysis was completed excluding all participants with MMSE scores <24 and 
MoCA scores <26 to assess for the potential differences in underlying cognitive status between 
groups to influence the results related to IPS and attention. This resulted in the exclusion of 1 
control subject and 5 NOH patients. Of note, the control subject had a MoCA score of 25 and an 
MMSE score of 29 and as such we did not feel elimination of this patient from the control group 
during the original analysis was warranted. When these 6 participants were excluded, NOH 
patients still had worse attention in the HUT position compared to controls, but this difference was 
no longer significant (p = 0.066). Therefore, when participants with pre-existing cognitive 
dysfunction were excluded only this one finding was altered. 
 
3.4 Discussion 
It is evident from the findings of the current study that NOH patients have undergone an alteration 
in cognitive function compared to healthy age-matched controls.  NOH patients had significantly 
slower IPS than controls in both the supine and HUT positions. Controls had a significant increase 
in IPS and attention in the HUT position compared to supine, whereas NOH patients had no 
difference in IPS or attention with a change in position. NOH patients had significantly worse 
attention in the HUT position compared to controls. Overall, findings demonstrate that IPS and 
attention are impaired in NOH patients compared to controls. 
 
It is important to note that NOH patients with slightly lower baseline cognitive functioning did not 
cause significant differences in SDMT or Stroop test scores compared to the NOH group as a 
whole. NOH patients with low MoCA scores (≤ 25) did not have significantly worse IPS or 
attention than NOH patients with high MoCA scores (≥ 28) in either the supine or HUT position. 
Therefore, it can be stated that NOH patients had significantly worse IPS and attention compared 
to controls and this finding was not only caused by NOH patients with low MoCA scores, but it 
was a result caused by the NOH group as a whole. 
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During HUT, NOH patients experienced a significant drop in SBP (-64.11 ± 18.96mmHg), 
demonstrating the severity of their condition. This extreme drop in SBP could be contributing to 
why they had worse cognitive function than controls. The current study found no significant 
correlation between the change in SBP during HUT and SDMT score or interference score in NOH 
patients or controls. Therefore, when changes in SBP occurred it did not relate to changes in IPS 
or attention. NOH patients experienced a significant decrease in SBP during HUT and had no 
significant change in IPS or attention compared to baseline. However, control subjects experienced 
very little change in SBP from the supine to HUT position but experienced a significant increase 
in IPS and attention during HUT. These results contradict other studies suggesting that cognitive 
function declines in patients with autonomic failure in the HUT position compared to supine 18–20. 
Our findings are consistent with one study investigating patients with autonomic failure. Patients 
had a SBP drop of 61.4 mmHg  during HUT and had no change in sustained attention from the 
supine to HUT position, whereas controls had better sustained attention in the HUT position 
compared to supine 21. Consequently, the large drop in SBP experienced by NOH patients did not 
cause a worsening in IPS or attention, but it could be a factor as to why NOH patients did not 
experience an increase in IPS and attention during HUT like the controls.  
 
Interestingly, NOH patients had significantly worse SDMT scores in the supine position compared 
to controls but experienced no drop in SBP in this position. This indicates that regardless of 
position NOH patients had slower IPS compared to controls. Prior research investigating cognitive 
function in individuals who experience a large drop in BP upon standing have found that these 
individuals also have alterations in many cognitive domains 4,22–27. Heims et al. documented that 
out of 14 individuals with pure autonomic failure 43% showed cognitive impairment in speed, 
attention, and executive functioning when tested in the seated position 4. A battery of 
neuropsychological tests was completed in the seated position in 961 community dwelling 
individuals. Participants with systolic orthostatic hypotension had worse global cognition, verbal 
memory, and scanning and tracking scores than individuals with a normal systolic BP change 22. 
Orthostatic hypotension (OH) was associated with worse cognitive function 26, as well as poorer 
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global cognitive function and poorer memory, in women aged 65 and above 23. Bocti et al. 
administered multiple neuropsychological tests to 2 groups of people; group 1, individuals with 
mild cognitive impairment (MCI) and OH and group 2, individuals with MCI without OH. 
Individuals with MCI and OH had a lower processing speed, visual working memory, and 
executive function compared to individuals without OH 24. Together these studies demonstrate that 
repeated exposure to low BP may contribute to a decline in a variety of cognitive domains 
regardless of position. Our results strongly argue that IPS is among the earlier domains to be 
affected given that we controlled for significant other cognitive dysfunction by requiring normal 
values on standardized clinical tests of cognition (i.e. MMSE and MoCA). 
 
Attention measured by Golden’s interference score was significantly reduced in NOH patients 
compared to the controls in the HUT position. As well, NOH patients had no significant difference 
in attention from supine to HUT, but controls had a significant increase in attention from supine 
to HUT. It is important to note that although not significant (p = 0.592) NOH patients had slightly 
better attention in the supine position than controls. This was a surprising finding and may be a 
result of the way Golden’s interference score is calculated since it takes into consideration a 
predicted colour-word score. Prior research has reported that using this interference score can be 
problematic in patient populations who have reduced IPS 28,29. When IPS is impaired it can result 
in lower scores on the word trial and the colour trial of the Stroop test which results in a lower 
predicted colour-word score being calculated. A low predicted colour-word score is beneficial 
because it allows the participant to score low on the colour-word trial without worsening the 
interference score. In the current study, the raw score for the colour-word trial was lower in NOH 
patients in both the supine and HUT positions than the controls. Consequently, this demonstrates 
that NOH patients perform worse on the task although their interference is not significantly worse 
in the supine position. 
 
Cerebral autoregulation maintains constant blood flow to the brain even when large fluctuations 
in systemic BP occur. It has been established that SBP can range from 80 to 160mmHg and cerebral 
blood flow will remain constant because of cerebral autoregulation. However, once mean BP drops 
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below 80mmHg this can cause a decrease in cerebral blood flow velocity 30. This was demonstrated 
in multiple system atrophy where presyncopal patients had a decrease in SBP and a corresponding 
reduction in cerebral oxygenation during HUT 31. Hunt et al. found a decrease in  mean arterial 
pressure by 46.7 ± 26.5mmHg, which was associated with a reduction cerebral oxygenation by 8.6 
± 6.2% during HUT  32. In the current study, 13 of the 20 NOH patients had a SBP of <80mmHg 
during HUT. These BP reductions are likely disrupting the normal regulation of cerebral blood 
flow in NOH patients. Consequently, monitoring cerebral hemodynamics in individuals with NOH 
could show an important link between BP and orthostatic symptoms. Future research investigating 
the changes in cerebral hemodynamics in NOH patients could reveal if these changes are a factor 
contributing to the impaired IPS and attention. Further work is continuing in our laboratory to 
address these issues.  
A limitation of the current study was that all participants began cognitive testing in the supine 
position. Randomizing participants to start cognitive testing in either supine or HUT position may 
be beneficial. This would illustrate if cognitive test scores were affected by repeating the test in 
the HUT position after the supine position. The current study showed no change in cognitive test 
scores in NOH patients between the supine and HUT positions, demonstrating no learning effect 
associated with the tests. The current study did not randomize starting position because our 
experimental design followed the standardized HUT procedure 15. An important limitation to note 
was that the NOH group had significantly lower MMSE and MoCA scores compared to controls, 
demonstrating a difference in baseline cognitive function. Reduced cognitive function in the 
patient group could be due to the underlying neurodegenerative disease since patients had 
conditions such as Parkinson’s disease, multiple system atrophy, and Lewy body dementia. 
Therefore, future research should recruit a population with only PAF patients since this condition 
is not associated with cognitive changes. Another limitation was that the groups had a modest 
asymmetry of recruitment based on gender. However, statistical analysis did not reveal a 
significant effect of gender on our results.  
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3.5 Conclusion 
The current study provides evidence that IPS is significantly reduced in individuals with NOH in 
both the supine and HUT positions compared to controls. Attention is also reduced in NOH patients 
compared to controls in the HUT position. These findings demonstrate that NOH patients have 
deficits in cognitive function compared to controls. NOH patients had no significant change in IPS 
or attention from the supine to HUT positions. Therefore, patients with NOH should be informed 
that they may have difficulty with how quickly they process information and that their attention 
may be reduced. They should be instructed to take caution when performing daily activities in the 
standing position to help reduce associated risks.   
 
This research did not receive any specific grant from funding agencies in the public, commercial, 
or not-for-profit sectors. Declarations of interest: none 
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Chapter 4 
 
4 The influence of cerebral hemodynamics on information 
processing speed and attention in patients with 
neurogenic orthostatic hypotension 
 
4.1 Introduction 
Cerebral blood flow requires a complex vascular system to transport oxygen and nutrients to the 
most important organ, the brain. Cerebral autoregulation is a mechanism used to ensure the brain 
receives adequate blood supply 1. Findings have demonstrated that the autonomic nervous system 
(ANS) is involved in regulating cerebral autoregulation. Alterations to the ANS can cause a 
significant decrease in cerebral blood flow velocity (CBFv), systolic pressure, and pulse pressure 
2. Biochemical evidence has suggested that the sympathetic nervous system (SNS) affects CBFv 
3. Consequently, damage or modification of the ANS disrupts cerebral autoregulation. 
 
Neurological conditions that involve ANS damage are often associated with cerebral 
hypoperfusion 4. Neurogenic orthostatic hypotension (NOH) is a condition that results from 
autonomic failure and is associated with numerous neurological diseases including Parkinson’s 
disease, Multiple system atrophy, and Lewy body dementia 5. NOH presents with a severe drop in 
systolic blood pressure (SBP) ≥ 20mmHg or diastolic blood pressure (DBP) ≥ 10mmHg within 
three minutes of standing up or head-up tilt (HUT)  6. Therefore, every time an individual with 
NOH stands up, they may feel lightheaded, dizzy, weak, and confused. Repeated exposure to 
orthostatic challenges with severely reduced BP can lead to cerebral hypoperfusion 7, which can 
provoke deficits in cognitive function.  
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Common techniques used to assess cerebral hemodynamics include transcranial doppler (TCD) 
which can measure cerebral blood flow velocity (CBFv) in the middle cerebral arteries and near 
infrared spectroscopy (NIRS) which measures regional cerebral oxygen saturation (rSO2) in the 
frontal lobes. Measures of CBFv and rSO2 display critical information about the immediate 
cerebral blood supply. Inadequate cerebral blood supply has been associated with damage to brain 
tissue and deficits in cognitive function. For example, insufficient CBFv can induce brain damage 
through ischemic injury 8. Cerebral hypoperfusion can cause white matter lesions, which can lead 
to cognitive impairment due to disruptions in the neural networks 9.  It was found that decreased 
CBFv in individuals with white matter lesions was associated with greater subcortical brain 
atrophy 10.  
 
Information processing speed (IPS) and attention are two important cognitive domains that are 
necessary to perform daily activities. IPS is a measure of time between receiving a stimulus and 
responding to that stimulus 11. Attention is the ability to attend to a stimulus of interest without 
being distracted by surrounding stimuli 12. Even in the early stages of neurological diseases such 
multiple sclerosis (MS), IPS is severely impaired 13–15. Previous research found that individuals 
with NOH have decreased cognitive function, including reduced executive functions 16, immediate 
visual memory, and global cognitive functioning 17. Patients with pure autonomic failure (PAF) 
presented with deficits of executive functioning, speed, and attention 18. Individuals with Lewy 
body dementia and orthostatic hypotension had worse visuospatial and attentional dysfunction 
even after adjusting for cognitive impairment. These individuals also had reduced CBFv in the 
occipital and temporal lobes 19. It is evident that neurological conditions associated with NOH 
have greater impairment of cognitive function. Additionally, there are a limited number of studies 
examining the role of CBFv, rSO2, and BP in NOH patients. Further characterization of cerebral 
hemodynamics in these patient groups are likely to provide key insights into the reason why these 
individuals suffer from greater cognitive deficits. Consequently, further research is important to 
determine if the reduction in IPS and attention are affected by changes in cerebral hemodynamics.   
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The objectives of the current study were two-fold. The first objective was to determine the effects 
of postural blood pressure changes in NOH verses control subjects on cerebral hemodynamic 
parameters (i.e. CBFv and rSO2). The second objective was to investigate cerebral hemodynamics 
during tests of IPS and attention.  
 
It was hypothesized that NOH patients would experience a reduction in CBFv and rSO2 in the 
HUT position compared to the supine position, whereas controls would experience no changes in 
CBFv and rSO2 with the change in position. 
 
4.2 Methods  
4.2.1 Participants  
Forty-three participants were enrolled in the study. Three NOH patients were excluded because 
they were unable to remain in the upright position for the duration of testing. Of the 40 participants, 
20 had a diagnosis of NOH provided by a neurologist and 20 were healthy age-matched control 
subjects. To diagnose NOH the neurologist evaluated the results of an autonomic reflex screen, 
completed a neurological examination, and collected a medical history. A criterion of SBP ≥ 
30mmHg was used to determine the diagnosis of NOH rather than the more liberal criteria (i.e. 
SBP ≥ 20mmHg or DBP ≥ 10mmHg). This was to reduce the false positive rate from 5% to 1 % 
20. Participants were excluded from the study if they were taking medication that could interfere 
with the regulation of BP or heart rate (HR), clinically significant coronary artery disease, presence 
of nerve damage in the peripheral nervous system, failure of other organ systems or diseases that 
can affect autonomic function, visual problems, the inability to remain in the upright position for 
the duration of testing. Testing was performed in the autonomic lab located at the University 
Hospital in London, Ontario. Written informed consent was provided before participants were 
enrolled in the study. The Health Science Research Ethics Board at Western University granted 
ethical approval for the current study.  
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4.2.2 Physiological Measures  
A standardized autonomic reflex screen (ARS) was used to assess the integrity of the ANS 21. The 
ARS evaluates the quality of the postganglionic sympathetic sudomotor axons using the 
quantitative sudomotor axon reflex test, cardiovagal function using a deep breathing test and the 
Valsalva maneuver, and adrenergic function using the Valsalva maneuver and head-up tilt (HUT).  
 
During testing participants were connected to a HR monitor (Model 3000 Cardiac Trigger Monitor, 
IVY Biomedical Systems, Inc., Branford, CT) attached using electrocardiography electrodes 
(Ambu® Blue Sensor SP, Glen Burnie, MD). Electrode placement was as follows; one just below 
the right clavicle, one just below the left clavicle, and one on the lower chest just above and left of 
the umbilicus. Participants were also connected to a beat-to-beat BP monitor (BMEYE Nexfin 
device, Amsterdam, Netherlands) fastened on the middle finger. TCD probes at 2MHz were 
positioned over the left and right middle cerebral arteries to continuously measure CBFv (Multigon 
500M, DWL MultiDop-T, Neuroscan). The probes were fastened in place with an adjustable 
plastic headpiece. The strongest CBFv signal on either the left or right side was used for analysis. 
NIRS was used to measure rSO2 in the left and right frontal lobes (NIRS ForeSight® cerebral 
oximeter, CASMED, Branford, CT). WR TestWorks TM software (WR Medical Electronics Co., 
Stillwater, MN) was used to record data. 
 
4.2.3 Cognitive Measures  
The Mini-Mental State Examination and the Montreal Cognitive Assessment were used to 
clinically screen participants to ensure they did not have any cognitive impairment. Two paper 
based neuropsychological tests were used to assess cognitive function; the oral version of the 
Symbol Digit Modalities Test (SDMT) to measure IPS and the Stroop test to measure attention. 
The SDMT is a sheet of paper with a key at the top of the page containing the numbers 1 to 9 and 
each number corresponds with a symbol below. Underneath the key there are 8 rows containing 
15 symbols each. Participants were given 90 seconds to say out loud as quickly as possible the 
digit associated with each symbol 22. The Stroop test consists of three subtests each containing 100 
words of colours (purple, blue, red, green, and brown) and lasting 45 seconds in duration. The first 
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test is composed of words of colours written in black ink. The second test is composed of words 
of colours printed in the same colour ink as the word. In the third test the words of colours are 
printed in a colour of ink that does not correspond with the word. For example, the word blue could 
be printed in green ink. During this trial the participant must say the colour of the ink and inhibit 
themselves from saying the word. The number of correct responses and the number of errors were 
recorded for all tests.  
 
Before cognitive testing commenced 90 seconds was recorded in the supine position to provide 
baseline resting values for HR, MAP, CBFv, and rSO2. In the supine position cognitive testing 
was completed in the following order; SDMT, Stroop 1, SDMT, Stroop 2, SDMT, Stroop 3, 
SDMT. The bed was then tilted to the HUT position (70 degrees upright) and 90 seconds was 
recorded in this position before cognitive testing began. Cognitive testing in the HUT position was 
as follows; Stroop 1, Stroop 2, Stroop 3, SDMT. Total time in the upright position was about seven 
minutes. Upon completion of cognitive testing the bed was tilted back to the supine position and 
the participant was given five minutes of recovery. 
 
4.2.4 Statistical Analysis  
Characteristics such as age, BMI, HR and BP were compared between groups using independent-
samples t-tests. Cognitive testing in the supine and HUT positions was compared using a two-way 
mixed ANOVA. CBFv, rSO2, and MAP were measured during baseline, cognitive testing, and 
HUT and were analyzed using a two-way mixed ANOVA. These measures were also compared 
between NOH and controls using independent-samples t-tests. Repeated measures with a 
Bonferroni correction was used to compare each position to baseline. All data are expressed as 
mean ± SD. A significance level of p < 0.05 was used. SPSS statistics software, Version 25, 
Manufactured by International Business Management (IBM) Corporation was used for the 
statistical analysis.  
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4.3 Results 
4.3.1 Participants  
Various characteristics of NOH patients and controls are presented in Table 3. Participants with 
NOH had the following associated conditions; Parkinson’s disease (n=11), multiple system 
atrophy (n=3) and early Lewy body dementia based on preganglionic dysfunction (n=1) and 5 
participants had a diagnosis of idiopathic NOH. Controls and NOH patients were matched based 
on age, BMI, and education level. There were no significant differences found based on gender 
even though there was a slight difference in the female to male ratios. There was no significant 
difference in resting HR, resting BP, or the change in HR between groups. The change in SBP 
during HUT was significantly greater in NOH patients (64.11 ± 18.96) than controls (-5.69 ± 7.65).  
 
Table 3. Participant Characteristics 
 
Characteristic  Control 
(mean ± SD) 
NOH 
(mean ± SD) 
P-value 
Age (years) 64.50 ± 9.25 69.55 ± 7.43 p = 0.065 
Gender (F:M) 12:8 8:12  
Education Level (>high school) 16 13  
BMI (kg/m2) 21.50 ± 2.51 22.02 ± 4.71 p = 0.67 
Resting HR (bpm) 69.49 ± 11.91 74.28 ± 12.85 p = 0.228 
ΔHR during HUT (bpm) 15.04 ± 6.27 12.12 ± 8.60 p = 0.227 
Resting SBP (mmHg) 128.12 ± 18.75 139.50 ± 23.72 p = 0.101 
ΔSBP during HUT (mmHg) -5.69 ± 7.65 -64.11 ± 18.96 * p < 0.001* 
BMI: body mass index, bpm: beats per minute, HR: heart rate, HUT: head-up tilt, mmHg: 
millimeters of mercury, NOH: neurogenic orthostatic hypotension, SBP: systolic blood pressure. 
* Represents significant difference of p < 0.001. 
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4.3.2 SDMT and Stroop Test Scores 
NOH patients scored significantly worse on the SDMT in both the supine and HUT positions 
compared to the controls (p < 0.001), demonstrating significantly slower IPS. NOH patients had 
no significant difference in IPS from supine to HUT, whereas controls had a significant increase 
in IPS in the HUT position compared to supine. NOH patients also scored significantly worse on 
the Stroop test in the HUT position compared to controls, indicating worse attention. Controls had 
significantly better attention in the HUT position compared to the supine position, whereas the 
NOH patients had no significant difference (Table 4). 
 
Table 4. Cognitive test scores in Supine and HUT Positions 
 
Cognitive Test Position Control 
(mean ± SD) 
NOH 
(mean ± SD) 
P-value 
SDMT Supine 63.55 ± 9.96 43.20 ± 15.26 p < 0.001* 
HUT 69.90 ± 12.02 42.90 ± 14.33 p < 0.001* 
Stroop Test Supine -14.01 ± 8.96 -12.38 ± 9.32 p = 0.592 
HUT  -8.68 ± 7.13 -14.86 ± 8.96 p = 0.029* 
HUT: head-up tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit modalities test. 
* Represents significant difference between groups 
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4.3.3 Cerebral Blood Flow Velocity 
Baseline values for CBFv were not significantly different between groups. Controls had a resting 
CBFv of 50.78 ± 10.79cm/sec and NOH patients of 47.83 ± 10.77cm/sec. During the Stroop test 
(Figure 10) and the SDMT (Figure 11) in the supine position there was no significant change in 
CBFv from baseline in either group. NOH patients had a significant decrease in CBFv by -
6.04cm/sec during HUT compared to baseline, whereas the control group had no significant 
change. During HUT, CBFv decreased significantly during the Stroop test by -6.24cm/sec and 
during the SDMT by -7.42cm/sec compared to baseline in NOH patients, whereas controls had no 
significant change in CBFv. CBFv was significantly different between NOH and controls during 
HUT, during Stroop testing in the supine and HUT positions and during the SDMT in the HUT 
position. 
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Figure 10. Cerebral Blood Flow Velocity during Baseline, Stroop Testing, and Head-up Tilt 
 
There was a significant decrease in CBFv from baseline compared to HUT and from baseline 
compared to Stroop test in the HUT position in the NOH group. Controls had no significant 
changes in CBFv. There were differences in CBFv between groups during Stroop testing in the 
supine and HUT positions. CON: control, HUT: head-up tilt, NOH: neurogenic orthostatic 
hypotension. a: p = 0.007 between baseline and HUT; b: p = 0.003 between baseline and HUT 
Stroop test; c: p = 0.017 between NOH and CON during supine Stroop test; d: p = 0.006 between 
NOH and CON during HUT Stroop test. 
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Figure 11. Cerebral Blood Flow Velocity during Baseline, SDMT Testing, and Head-up Tilt 
 
There was a significant decrease in CBFv from baseline compared to HUT and from baseline 
compared to SDMT in the HUT position in the NOH group. Controls had no significant changes 
in CBFv. There were differences in CBFv between groups during HUT and HUT SDMT. CON: 
control, HUT: head-up tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit 
modalities test. a: p = 0.003 between baseline and HUT; b: p = 0.002 between baseline and HUT 
SDMT; c: p = 0.036 between NOH and CON during HUT; d: p = 0.014 between NOH and CON 
during HUT SDMT. 
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4.3.4 Regional Cerebral Oxygen Saturation 
At baseline there was no significant difference in rSO2 between groups. Baseline rSO2 was 69.74 
± 3.55% for controls and 70.31 ± 4.58% for NOH patients. When cognitive testing commenced 
in the supine position rSO2 increased significantly in both groups by 3.78% and 1.55% during 
the Stroop test (Figure 12) and 4.25% and 1.85% during SDMT (Figure 13) in control and NOH 
groups respectively. During HUT, rSO2 decreased significantly from baseline by -1.85% in the 
NOH group and no significant change in the control group. During cognitive testing in the HUT 
position, NOH patients had a significant decrease in rSO2 during the Stroop test by -5.87% and 
during the SDMT by -5.48% compared to baseline. The controls had no significant change in 
rSO2 during cognitive testing in the HUT position compared to baseline. There were significant 
differences in rSO2 between NOH and controls during the HUT Stroop test and HUT SDMT. 
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Figure 12. Cerebral Oxygen Saturation during Baseline, Stroop Testing, and Head-up Tilt 
 
Controls and NOH had a significant increase in rSO2 between baseline and Stroop testing in the 
supine position. NOH patients experienced a significant decrease in rSO2 between baseline and 
HUT and between baseline and Stroop testing in the HUT position. There was a difference in rSO2 
between groups during HUT Stroop test. NOH: neurogenic orthostatic hypotension, CON: control, 
HUT: head-up tilt. a: p = 0.00009 between baseline and Stroop testing in the supine position; b: p 
= 0.019 between baseline and Stroop testing in the supine position; c: p = 0.041 between baseline 
and HUT positions; d: p = 0.0001 between baseline and Stroop testing in the HUT position; e: p = 
0.029 between NOH and CON during the HUT Stroop test.  
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Figure 13. Cerebral Oxygen Saturation during Baseline, SDMT Testing, and Head-up Tilt  
Controls and NOH had a significant increase in rSO2 between baseline and SDMT testing in the 
supine position. NOH patients experienced a significant decrease in rSO2 between baseline and 
HUT and between baseline and HUT SDMT. There was a difference in rSO2 between groups 
during HUT SDMT. CON: control, HUT: head-up tilt, NOH: neurogenic orthostatic hypotension, 
SDMT: symbol digit modalities test. a: p = 0.003 between baseline and supine SDMT testing in 
CON; b: p = 0.043 between baseline and supine SDMT testing in NOH; c: p = 0.025 between 
baseline and HUT in NOH; d: p = 0.004 between baseline and  HUT SDMT testing in NOH; e: p 
= 0.013 between NOH and CON during the HUT SDMT. 
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4.3.5 Mean Arterial Pressure 
Mean arterial pressure (MAP) at baseline was not significantly different between groups. Resting 
MAP for controls was 94.02 ± 15.01mmHg and 92.87 ± 19.66mmHg for NOH patients. There was 
no significant change in MAP during cognitive testing in the supine position compared to baseline 
in either group. During HUT there was a significant decrease in MAP from baseline in the NOH 
group, MAP dropped by -24.62mmHg, whereas there was no significant change in controls. MAP 
remained significantly reduced from baseline during the Stroop test in the HUT position (Figure 
14) and the SDMT in the HUT position (Figure 15), MAP decreased by -19.25mmHg and -
24.02mmHg, respectively. There was no significant change in MAP in the control group during 
cognitive testing in the HUT position. MAP was significantly different between groups during 
HUT and during HUT Stroop and HUT SDMT. 
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Figure 14. Mean Arterial Pressure during Baseline, Stroop Testing and Head-up Tilt 
 
NOH patients experienced a significant decrease in MAP between baseline and HUT and between 
baseline and HUT Stroop testing. Controls had no significant changes in MAP. There were 
differences in MAP between groups during HUT and HUT Stroop test. CON: control, HUT: head-
up tilt, NOH: neurogenic orthostatic hypotension. a: p = 0.004 between baseline and HUT; b: p = 
0.035 between baseline and HUT Stroop testing; c: p = 0.006 between NOH and CON during 
HUT; d: p = 0.0002 between NOH and CON during the HUT Stroop test. 
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Figure 15. Mean Arterial Pressure during Baseline, SDMT Testing and Head-up Tilt  
NOH patients experienced a significant decrease in MAP between baseline and HUT and between 
baseline and HUT SDMT testing. Controls had no significant changes in MAP. There were 
differences in MAP between groups during HUT and HUT SDMT. CON: control, HUT: head-up 
tilt, NOH: neurogenic orthostatic hypotension, SDMT: symbol digit modalities test. a: p = 0.0004 
between baseline and HUT; b: p = 0.01 between baseline and HUT SDMT testing; c: p = 0.001 
between NOH and CON during HUT; d: p = 0.0001 between NOH and CON during HUT SDMT. 
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4.4 Discussion 
Findings demonstrated that NOH patients had significantly impaired CBFv, rSO2, and MAP during 
HUT. NOH patients had a significant decrease in these three measurements during HUT compared 
to baseline, whereas controls had no significant difference. Baseline values for mean CBFv, rSO2, 
and MAP were not significantly different between groups. This revealed that the two groups had 
similar resting hemodynamic values. These measures differed significantly between groups during 
the orthostatic challenge and during cognitive testing. Previous research analyzing changes in 
CBFv, rSO2, and MAP presented similar findings 
23–27. A five minute orthostatic challenge 
produced a larger decrease in MAP and rSO2 in patients with sympathetic failure than controls 
25. 
A study assessed changes in cerebral hemodynamics during HUT in 18 patients with autonomic 
failure and 10 controls. Results showed that 10 minutes of HUT caused a greater reduction in MAP 
(-46.7 ± 26.5mmHg) and cerebral oxygenation (-8.6 ± 6.2%) in patients than controls 28. It was 
found that 13 individuals with orthostatic hypotension had decreased MAP (-19.1 ± 11.6mmHg) 
and cerebral oxygenation (-5.4 ± 4.2%) during HUT 23.  During HUT, individuals with multiple 
system atrophy who experienced presyncopal symptoms had a significant decline in SBP and a 
corresponding reduction in rSO2 
26. Therefore, it has been established that individuals who 
experience a significant drop in BP upon standing likely have profound changes in cerebral 
hemodynamics.   
 
An interesting finding was that rSO2 increased significantly from baseline in both the NOH patients 
and controls when cognitive testing commenced in the supine position. This increase in rSO2 with 
no positional change reveals that cognitive testing likely triggered the rise in rSO2. Attention and 
IPS was required to complete the cognitive tasks, consequently the region of the brain responsible 
for these cognitive functions had an increased metabolic demand. Evidence has supported the 
finding that cognitive testing causes an increase in rSO2.  It has been stated that increased in rSO2 
demonstrates increased neural activity, which is necessary during cognitive testing. A group of 
highly fit women had better cognitive performance than a group of low fit women likely due to 
the fact that the highly fit women also experienced a greater increase in rSO2 
29. In the current 
study, NOH patients had lower rSO2 during cognitive testing and had worse cognitive test scores 
than controls. Consequently, reduced rSO2 could be contributing to impaired cognitive function. 
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A study assessing patients undergoing chronic hemodialysis demonstrated that rSO2 was 
significantly lower in cognitively impaired patients compared to cognitively normal patients (48 ± 
9 vs. 57 ± 10%, p = 0.01) 30.  It is apparent that reduced rSO2 is related to changes in cognitive 
function.  
 
The second objective of the study was to assess cerebral hemodynamics and investigate if it 
changes during cognitive testing in the supine and HUT positions. The current study provides 
insight that NOH patients had an alteration in cerebral hemodynamics which can help provide a 
reason as to why these individuals also have decreased IPS and attention compared to controls. 
NOH patients had a significant decrease in CBFv and rSO2 compared to baseline during cognitive 
testing in the HUT position suggesting that during this time oxygen availability was insufficient 
to meet the metabolic demands of the cognitive processes 31. Compared to controls, NOH patients 
had significantly reduced CBFv and rSO2 during cognitive testing in the HUT position and reduced 
CBFv during the Stroop test in the supine position. Cerebral hypoperfusion occurs in the upright 
position in NOH patients and is likely playing a role in why they have impaired cognitive 
functioning. Surprisingly, NOH patients had no significant difference in IPS or attention when 
they changed position from supine to HUT but compared to controls had significantly worse IPS 
and attention. Therefore, NOH patients had impaired IPS and attention regardless of their position. 
These findings are in line with a study that assessed 10 patients with symptomatic NOH and 10 
healthy controls. They found that NOH patients had no significant difference in sustained attention 
from the supine to HUT position but the controls did have a significantly better attention in HUT 
position 32. It is important to note that controls had an increase in CBFv and a significant increase 
in rSO2 during cognitive testing in the supine position compared to baseline values. As well, 
controls also had an increase in CBFv during cognitive testing in the HUT position compared to 
HUT values. These findings indicate that cerebral hemodynamic values may increase during 
cognitive tasks since they trigger an increase in cognitive activation.  
 
In the current study, controls had a significant increase in attention and IPS in the HUT position 
compared to supine. The activity of standing results in an increase in sympathetic activation which 
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may contribute to a brief improvement in cognitive function. When cognitive tasks are performed 
they elicit greater sympathetic nervous system activation 33. It has been stated that greater 
sympathetic activity is associated with improved attention processing and greater parasympathetic 
activity is an indicator of increased selective attention 34. Given that NOH patients have no 
improvement or possibly worse cognitive function in the standing position reveals that the ANS 
damage in this group of individuals that results in impaired sympathetic activation could result in 
this cognitive dysfunction. This provides evidence that deficits in cognitive function experience 
by NOH patients are partly due to direct ANS damage 
 
Our study proposes that NOH patients have impaired cognitive function independent of position. 
NOH patients experience repeated exposure to cerebral hypoperfusion. This could be related to 
why they have a persistent deficit in cognitive functioning. When SBP drops below 80mmHg, 
cerebral autoregulation may not be able to function properly resulting in decreased cerebral blood 
flow. Individuals with neutrally mediated syncope are close to losing consciousness when SBP 
drops to 60mmHg, at this time they also experience a large reduction in mean CBFv to 30cm/s 35. 
It has been stated that cerebral hypoperfusion has negative consequences on brain structures 8,9. 
Therefore, daily exposure to reduced CBFv, rSO2, and MAP elicited by an orthostatic challenge 
could damage the integrity of neural connections involved in cognitive processes. For example, 
cerebral white matter damage has been strongly associated with decreased executive functions and 
IPS 36. Alterations in BP and cerebral hemodynamics are likely a contributing factor to the decline 
in cognitive function.  
 
The current study consisted of a diverse patient population, but as a group these patients had a 
homogeneous drop in BP as a result of autonomic function. Patients had a diagnosis of NOH but 
had different associated conditions, such as Parkinson’s disease, multiple system atrophy, and 
Lewy body dementia. Future studies could repeat this protocol with a specific group of patients, 
for example Parkinson’s disease patients with NOH. This could provide evidence if the changes 
in cerebral hemodynamics and cognitive function are related to NOH or the associated condition. 
Another limitation of the study was that some participants only had unilateral TCD recordings if a 
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signal could not be obtained bilaterally. Bilateral recordings are important since CBFv responses 
during cognitive tasks strongly differ between hemispheres 37,38. Fortunately, most of the 
participants in the current study had bilateral recording but not all, consequently we measured the 
strongest recording obtained. Therefore, future studies should attempt to attain bilateral TCD 
recordings on all participants when assessing cognitive function.    
 
4.5 Conclusion 
The current study has provided evidence that NOH patients experience decreased CBFv and rSO2 
during an orthostatic challenge which could be a contributing factor to impaired IPS and attention. 
NOH patients experienced reduced IPS and attention in both the supine and HUT positions 
compared to controls and have no significant difference in these cognitive processes with a change 
in position. Therefore, this decline in cognitive function in NOH patients is likely in part a result 
of daily exposure to hypoperfusion and damage of the ANS.  
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Chapter 5 
 
5 General Discussion 
This thesis aimed to determine if there was a relationship between NOH patients, cerebral 
hemodynamics, IPS and attention. Analysis of the data revealed that NOH patients had significant 
differences in cerebral hemodynamics and cognitive functioning compared to healthy controls. 
The findings of the current thesis support some and reject some of the hypotheses made.  
 
5.1 Supported and Rejected Hypotheses 
The first hypothesis that NOH patients would experience a decline in IPS and attention in the HUT 
position due to the associated reduction in postural BP compared to the supine position was 
rejected. Even though during HUT NOH patients had a large drop in SBP they experienced no 
significant difference in IPS or attention between the supine and HUT positions. The hypothesis 
that control subjects would have increased IPS and attention in the HUT position compared to the 
supine position was accepted. It was found that controls had significantly faster IPS and better 
attention in the HUT position compared to supine. This could be due to the fact that they experience 
a burst of sympathetic activity when they stand up, which could increase cognitive function. NOH 
patients have ANS damage therefore they lack the burst of sympathetic activity when they stand 
up and consequently do not experience an increase in IPS and attention. Overall, NOH patients 
had worse IPS in the supine and HUT positions compared to controls. As well, NOH patients had 
worse attention in the HUT position compared to controls. 
 
The second hypothesis predicted that the magnitude of the postural SBP drop would correspond 
with a worsening in IPS and attention. This hypothesis was rejected since no correlation was found 
between the postural SBP drop and IPS or attention in either NOH patients or controls. Therefore, 
the drop in SBP was not related to worse performance on the cognitive tasks.   
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The third hypothesis that NOH patients would experience a reduction in CBFv and rSO2 in the 
HUT position compared to the supine position was accepted. NOH patients experienced a 
significant reduction in both CBFv and rSO2 during the HUT position, therefore these measures 
were also reduced during cognitive testing in the HUT position. As well, the hypothesis that 
controls would experience no change in CBFv and rSO2 from the supine to HUT position was also 
accepted. This finding indicates that controls have adequate cerebral blood supply during cognitive 
testing in the HUT position. 
 
It is likely that the fourth hypothesis was accepted. It was predicted that reduced measures of CBFv 
and rSO2 could be related to a decline in IPS and attention. Evidence to support this hypothesis is 
that NOH patients have significantly reduced IPS and attention compared to controls and they also 
experience reductions in cerebral blood supply when they are in the upright position. It is believed 
that repeated exposure to reduced CBFv and rSO2 could lead to a decline in cognitive functioning.  
 
The most important finding was that overall NOH patients had reduced IPS compared to controls 
regardless of their position. Therefore, IPS is permanently reduced in NOH patients compared to 
controls. Reduced IPS and attention could be related to the fact that NOH patients experience 
repeated episodes of cerebral hypoperfusion every time they perform an activity in the upright 
position. Consequently, exposure to cerebral hypoperfusion could be negatively affecting 
cognitive function. 
 
5.2 Strengths and Limitations  
There were several strengths with regards to the current study. This study investigated a clinical 
population that is rarely studied and provided information about their cognitive function and 
cerebral hemodynamics. The current study assessed cognitive function in both the supine and HUT 
positions. It was beneficial to measure cognition in these two positions since NOH patients 
experience positional BP changes. There is limited literature about cerebral hemodynamics in 
 84 
 
NOH patients, therefore this study introduced information about these measurements during 
cognitive testing and during changes in position. Another strength of the current study was that a 
group of healthy age-matched control subjects was included to provide baseline cognitive function 
and cerebral hemodynamics, which was then compared to the NOH patients. 
 
Despite the strengths highlighted there were a few limitations of the current study. Randomizing 
participants to start cognitive testing in either the supine or the HUT position would have been 
beneficial. This would prove if cognitive test scores were affected by repeating the test in the HUT 
position after the supine position. The current study showed no change in cognitive test scores in 
NOH patients between the supine and HUT positions, demonstrating no learning effect associated 
with the tests. The study had a modest asymmetry in the male to female ratios in both the NOH 
and control groups. However, statistical analysis did not reveal a significant effect of gender on 
the results. The study consisted of a diverse patient population, but as a group these patients had a 
homogeneous drop in BP as a result of autonomic function. Patients had a diagnosis of NOH but 
had different associated conditions, such as PD, MSA, and LBD. Future studies should repeat this 
protocol with a specific group of patients, for example PD patients with NOH. This would provide 
evidence if the changes in cerebral hemodynamics and cognitive function are related to NOH or 
the associated condition.  
 
5.3 Future Directions  
Future research should aim to investigate if repeated exposure to cerebral hypoperfusion in NOH 
patients is related to changes in brain structure and function. This could provide evidence as to 
why NOH patients have permanently reduced IPS and attention compared to controls. Future 
research should also investigate other cognitive domains to determine if NOH patients have 
impairments in functions other than IPS and attention.  
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5.4 Conclusion 
This is the first study to investigate the relationship between NOH patients, cerebral 
hemodynamics and cognitive function in both the supine and HUT positions. Findings revealed 
that NOH patients had a significant decrease in CBFv and rSO2 during HUT compared to supine, 
as well NOH patients experienced reduced IPS and attention compared to control subjects.  
 
 86 
 
Appendices 
Appendix A. Copyright for Elsevier 
 
 87 
 
Appendix B. Montreal Cognitive Assessment 
 
 88 
 
Appendix C. Symbol Digit Modalities Test 
 
 
 89 
 
Appendix D. Stroop Colour-Word Test 
 
 
 
 
 
 
 
 
 
 
 90 
 
Appendix E. Research Ethics Approval Notice  
 
 
 91 
 
Curriculum Vitae 
 
Lindsay Robinson  
 
 
 
Post-secondary  The University of Western Ontario 
Education and  London, Ontario, Canada 
Degrees:   BSc in Kinesiology 
2013 - 2017 
 
The University of Western Ontario 
London, Ontario, Canada 
MSc in Kinesiology  
2017 - 2019 
 
 
 
Intercultural   The University of New South Wales 
Experience   Sydney, New South Wales, Australia      
   Exchange student studying Exercise Physiology       
January - June 2016 
 
 
 
Related Work  Graduate Teaching Assistant 
Experience:   The University of Western Ontario 
   Courses: Systemic Approach to Functional Anatomy 
Laboratory in Exercise Physiology 
2017 – 2019 
 
Physiotherapist Assistant 
Tillsonburg Physiotherapy Clinic                                 
 Summer 2015 & 2016 
 
 
Volunteer  Connect Speech Language & Swallowing Services              
Experience:  London, Ontario, Canada 
2018 - Present 
 
Learning it Together 
   London, Ontario, Canada 
Tutored children to help improve their literacy and numeracy skills 
2016 – 2017  
 92 
 
Frontier College  
London, Ontario, Canada 
Volunteer at the Boys & Girls Club to tutor youth         
2014 –2015  
 
 
Tillsonburg District Memorial Hospital                         
Tillsonburg, Ontario, Canada 
Volunteer in the Emergency Department 
2012 – 2013  
 
 
Publications:  Submitted: Robinson, L. & Kimpinski, K. Neurogenic orthostatic 
 hypotension impairs information processing speed and attention. 2019
 Physiology and Behavior.  
In Progress: Robinson, L. & Kimpinski, K. The influence of cerebral 
hemodynamics on information processing speed and attention in patients 
with neurogenic orthostatic hypotension. 2019 
 
 
Conferences  53rd Annual Congress of the Canadian Neurological Sciences Federation  
Attended:   Halifax, Nova Scotia, Canada 
   Poster Presentation  
June 2018 
 
 
Honours and   Western Graduate Research Scholarship 
Awards:  2017-2019 
 
International Learning Scholarship 
2015 
    
Western Study Abroad Bursary 
2015  
 
Western Scholarship of Distinction 
2013  
 
 
 
 
 
